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Chapter I: BACKGROUND AND LITERATURE REVIEW 
Introduction 
Coronaviruses are a family of positive stranded RNA viruses that are important 
pathogens of humans and animals. They cause up to 15% of common colds and have 
been implicated in more serious diseases including croup, asthma exacerbations, 
bronchiolitis, and pneumonia (Denison, 2011; Perlman and Netland, 2009). Evidence also 
suggests that coronaviruses may cause enteritis or colitis in neonates and infants and may 
be underappreciated as agents of meningitis or encephalitis (Denison, 2011). Four 
coronaviruses are endemic in humans: human coronaviruses (HCoV) 229E, OC43, NL63, 
and HKU1. In addition, two epidemics of previously unknown coronaviruses caused 
significant respiratory distress and high mortality rates among infected individuals. The 
discovery of SARS-associated coronavirus (SARS-CoV), the cause of severe acute 
respiratory syndrome (SARS) in 2003, and of Middle East respiratory syndrome 
coronavirus (MERS-CoV) in 2012 support the potential for coronaviruses to emerge from 
animal hosts to become human pathogens with great capacity for morbidity and 
mortality. In addition to being a burden on human health, coronaviruses are also 
important agricultural pathogens, as they can infect cows, pigs, birds, cats, dogs, rodents, 
and many more exotic species which contributes to their zoonotic potential (Masters, 
2006).   
 
Coronaviruses are enveloped viruses of large size (80-220 nm) (Figure 1) that possess the 
largest known single-stranded positive-sense RNA genome. Coronaviruses derive their  
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Figure 1. Coronavirus Virion 
Coronaviruses derive their name from the spike proteins protruding from the surface, 
which resemble a corona, or sun. This can be seen in both the schematic and the electron 
micrograph. Virions are enveloped and pleomorphic, ranging in diameter from 80-220 
nm. Viruses derive their envelope from the ERGIC of the host cell.  The structural 
proteins Spike (S), Membrane (M), Envelope (E), and Nucleocapsid (N), are shown in 
the schematic. 
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name from the characteristic surface projections of spike protein, which give a corona or 
crown-like appearance on negative-stain electron microscopy (Masters, 2006). 
Coronaviruses are organized taxonomically by a lettering system based on genomic 
phylogenetic relationships (van Boheemen et al., 2012). Alphacoronaviruses include 
human coronavirus 229E (HCoV-229E) and HCoV-NL63. Betacoronaviruses include 
four human pathogens and the prototypical model virus, murine hepatitis virus (MHV). 
Betacoronaviruses are commonly divided into four lineages, without formal taxonomic 
recognition. HCoV-OC43 and the HCoV-HKU1 are in lineage A, while SARS-CoV falls 
in lineage B. Lineages C and D were exclusively comprised of bat coronaviruses until the 
discovery of MERS-CoV, which aligns with lineage C. Gammacoronaviruses and 
deltacoronaviruses presently include exclusively non-human pathogens (Perlman and 
Netland, 2009). 
 
Our laboratory utilizes MHV, SARS-CoV, and MERS-CoV, to investigate viral 
replication, viral evolution, and viral-cellular interactions. MHV replicates in the mouse 
nasopharynx before dissemination to sites of secondary replication, and SARS-CoV 
replicates in the nasopharynx and respiratory tract in mouse models. MHV is a powerful 
model for studying replication, pathogenesis and virus-host interactions, and is primarily 
used in the studies of this dissertation since MHV can be studied at BSL2, shares many 
conserved replication and pathogenesis characteristics with human CoVs, including 
SARS-CoV, has a well-established reverse genetic system and reagents, and can infect 
cell lines from multiple species expressing the MHV receptor, including cells able to 
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support SARS-CoV replication. Results from MHV experiments are directly applicable 
to and testable in SARS-CoV. 
 
The different strains of MHV vary in their pathogenesis. MHV-A59, the strain used as 
“WT” in the Denison lab and in this dissertation, has a dual tropism in mice with severe 
hepatitis and meningoencephalitis with chronic demyelination (Navas et al., 2001). 
Because of the demyelination phenotype, MHV-infected mice are also used as models for 
multiple sclerosis. MHV-2, however, causes hepatitis and meningitis but does not cause 
encephalitis or demyelination. MHV-2 and MHV-A59 have 91% genetic identity, but 
only 79% sequence identity within the spike protein. Differences in tropism and 
pathogenesis have been attributed to differences in the MHV spike protein, though the 
backbone of MHV-JHM has been shown to be able to impart pathogenicity in absence of 
MHV-JHM spike (Navas and Weiss, 2003). These differences in the spike proteins 
became valuable tools for much of the work in Chapter III of this dissertation. 
 
 
In 2002-2003, coronaviruses received international attention during the SARS outbreak, 
which was responsible for over 800 deaths in 30 countries and greater than 8000 cases. 
SARS-CoV, a novel coronavirus at the time of the epidemic, was found to be the 
causative agent of SARS (Kuiken et al., 2003; Peiris et al., 2003). The detection of 
SARS-like coronaviruses in a live animal market in the Guangdong province in Southern 
China, along with serologic evidence of exposure in food handlers in the same market, 
suggest that these markets may have facilitated the spread of SARS-CoV to humans from 
an animal reservoir. Once passed to humans, SARS was an explosive disease, with very 
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high person-person transmission rates (Hui et al., 2014). Subsequent studies identified 
SARS-like coronaviruses in fecal specimens from asymptomatic Chinese horseshoe bats 
that are very closely related, but not direct precursors to, SARS-CoV (Lau et al., 2005; Li 
et al., 2005). Finally, in 2013, two whole-genome sequences of novel bat CoVs were 
reported that are able to use ACE2 from humans, civets and Chinese horseshoe bats for 
cell entry, the strongest evidence to date that bats act as the reservoir for SARS-CoV 
without requiring an additional animal reservoir before transitioning to humans (Ge et al., 
2013).  
 
In June 2012, another novel coronavirus, MERS-CoV was isolated from a man with acute 
pneumonia and renal failure in Saudi Arabia (Zaki et al., 2012). By publication, an 
additional 826 cases had been confirmed in Saudi Arabia, Qatar, Jordan, and UAE, as 
well as cases in Malaysia, the United Kingdom, Italy, Tunisia, France, the United States, 
and the Netherlands involving patients who had traveled to the Middle East (Zumla and 
Memish, 2014). Two hundred and eighty-seven of these patients died due to their 
infection. Compared with SARS-CoV, MERS-CoV to date has a higher mortality, but 
appears to be less communicable by human-to-human transmission. MERS-CoV uses 
dipeptidyl peptidase 4 (DPP4) as its cellular receptor, while SARS-CoV utilizes ACE-2, 
and is able to infect cells from several animal lineages, including human, pig, and bat, 
suggesting the possibility of movement between multiple species (Raj et al., 2013). In a 
survey of bats in Europe and Ghana for β-coronaviruses, 46 of 185 Nycteris bats and 40 
of 272 Pipistrellus bats contained sequences from clade 2c betacoronaviruses 
phylogenetically related to MERS-CoV (Annan et al., 2013). In another study, one 
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Taphozous bat of 1100 samples from various species was found to have a small fragment 
of a CoV genome with sequence homology to MERS-CoV (Memish et al., 2013). 
Dromedary camels from the Canary Islands, Egypt, and Oman were shown to have 
neutralizing antibodies to MERS-CoV, but no viral genetic material was detected in sera 
or stool samples (Reusken et al., 2013). An investigation of virus sequences during an 
outbreak of MERS-CoV infection involving three camels and two humans on a Qatari 
farm demonstrated that people and camels be infected by the same strains, although the 
direction of transmission is not known (Haagmans et al., 2014). Another study looking at 
sera from camels in the UAE from 2003 determined that 97.1% of 151 samples had 
antibodies to MERS-CoV, suggesting that MERS-CoV has been a virus of camels long 
before its recent recognition in humans (Meyer et al., 2014). There is serological 
evidence that MERS-CoV has existed in the camel population since at least 1992, but it is 
unknown if the spillover event occurred before the first documented human case, or if it 
was stable in the camel population until recently (Alagaili et al., 2014). 
 
Coronaviruses pose a significant zoonotic threat to human health. This has been 
demonstrated by the emergence of two novel and dangerous coronaviruses within a 
decade, the capacity of coronaviruses to infect diverse animal species, and the prevalence 
of coronaviruses endemic to bat populations throughout the world. These characteristics 
suggest that future emergence of novel zoonotic coronaviruses is likely. 
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Coronavirus life cycle and replication 
The replication cycles of CoVs range from 6-24 hours. CoV infection is initiated by 
binding of the viral spike (S) glycoprotein to cellular receptors. Virus entry into cells 
occurs via direct fusion at the plasma membrane or by endocytosis (Figure 2). CoVs have 
27-32 kb positive-strand RNA genomes containing 7-9 genes (Figure 3) (Perlman and 
Netland, 2009). The 5’ most replicase gene comprises 2/3 of the genome and is composed 
of two open reading frames, ORFs 1a and 1b. Translation of genome RNA is initiated 
following entry into a host cell, first of ORF 1a and then of the longer ORF 1ab following 
a -1 ribosomal frameshift. The ORF1a and ORF1ab polyproteins are proteolytically 
processed by the papain-like proteases 1 and 2 (PLP1 and 2) in nsp3, and by the nsp5 
protease (3CLpro) to generate 16 nonstructural proteins (nsps1-16). Functions of nsp 1-
16 include RNA-dependent RNA polymerase (nsp12), helicase (nsp13), primase (nsp8), 
cap methylation (nsp14/16) and a novel proofreading exonuclease (nsp14). The 
exonuclease was identified by our lab and others and is the first known viral RNA 
proofreading enzyme, likely responsible for the evolution of the large and complex 
coronavirus genome (Eckerle et al., 2007; Perlman and Netland, 2009). Upon cleavage, 
nsp domains yield mature proteins that initiate viral genome transcription and replication 
on modified ER membranes in the cytoplasm, known as replication complexes, induced 
by replicase proteins nsps 3, 4, and 6 (Angelini et al., 2013).  
 
The downstream genes vary in number and organization, but encode structural proteins, 
including spike (S), envelope (E), membrane (M), and nucleocapsid (N), as well as 
several “accessory” proteins which may be dispensable for replication but serve roles in  
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Figure 2. Positive-stranded RNA viruses induce membrane rearrangements 
A-E. CoV infection is initiated by binding of the viral spike (S) glycoprotein to cellular 
receptors. Cellular entry occurs via direct fusion at the plasma membrane or endosomal 
uptake, depending on the virus strain. Nsp domains in the polyprotein are cleaved to yield 
mature proteins that initiate viral genome transcription and replication on modified 
cytoplasmic membranes, known as replication complexes, formed by replicase proteins 
nsps 3, 4, and 6. (B-C). Double membrane vesicles (DMVs) and convoluted membranes 
(CMs) make up the replication complexes, and DMVs are visible in the EM image (B) 
and the tomography image (C), where the DMVs are gold and purple and the CMs are 
orange. Following replication of genomic RNA, assembly of progeny virions occurs in 
the ER-Golgi intermediate compartment (ERGIC), with virion maturation and release via 
non-lytic secretory mechanisms. Cell surface expression of proteolytically mature S 
protein mediates interactions with receptors on adjacent cells resulting in fusion and 
syncytia formation. The fluorescent microscopy image in (D) demonstrates MHV-
infected cells forming syncytia, where spike is red, nsp8, a replication protein, is green, 
and nuclei are blue. Expression of S alone may be sufficient for syncytia formation. The 
fluorescent microscopy image in (E) demonstrates an MHV-infected syncytium forming 
a large plasma membrane ruffle. Green-F-actin. 	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Figure 3. Murine Hepatitis Virus Genome 
CoVs have 26-32 kb positive-strand RNA genomes containing 7-9 genes. The genome 
contains both a 5’ cap and a 3’ poly-A tail. The 5’ most replicase gene makes up 2/3 of 
the genome and is composed of two open reading frames, ORFs 1a/b. Translation into a 
single large polyprotein begins upon entry into a host cell, first of replicase ORF 1a and 
then ORF 1ab following a -1 ribosomal frameshift (RFS). The replicase polyproteins are 
proteolytically processed by the papain-like proteases 1 and 2 (PLP1 (pink) and 2 
(green)) in nsp3, and by the nsp5 protease (3CLpro/Mpro (black)) to generate 16 
nonstructural proteins (nsps1-16); functions include RNA-dependent RNA polymerase, 
helicase, primase, cap methylation and a novel proofreading exonuclease. Cleavage 
events are represented by the caret of the color corresponding to the protease. The 
remaining genes encode structural proteins and accessory proteins. 
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virus host interactions and immune evasion. Following replication of genomic RNA, 
assembly of progeny virions occurs in the ER-Golgi intermediate compartment (ERGIC), 
with virion maturation and release via non-lytic secretory mechanisms. For several CoVs, 
including MHV, cell surface expression of proteolytically mature S protein mediates 
interactions with receptors on adjacent cells, resulting in fusion and syncytia formation 
(Figure 2). For these viruses, expression of S alone is sufficient to cause cell fusion 
(Belouzard et al., 2009; Bertram et al., 2011).  
 
Coronavirus spike and fusion 
The coronavirus spike protein is a large, class I fusion protein that exists as a trimer on 
the surface of the virion. Class one fusion proteins form alpha-helical coiled-coil 
structures, with the prototype being the influenza HA (Belouzard et al., 2012). Spike is 
comprised of S1 and S2 subunits of approximately equal size, with S1 at the N terminus 
responsible for binding the receptor and S2 at the C terminus responsible for fusion 
(Figure 4).  Spike contains two heptad repeats in S2 (HR1 and HR2), as typical of class I 
fusion proteins. For both MHV and SARS-CoV, the post-fusion form of the protein has 
been solved and is known to form a six-helix bundle. In most alphacoronaviruses and 
some betacoronaviruses, the S1 and S2 subunits exist in an uncleaved state. For other 
betacoronaviruses, including MHV A59, and all gammacoronaviruses, the subunits are 
cleaved apart from each other, usually by the enzyme furin in the trans-Golgi, to activate 
the fusion function of the protein (Masters, 2006). Cleavage differences between MHV-
A59 and MHV-2, which is cleaved in the early endosome by cathepsins after entry via 
clathrin-dependent endocytosis (Pu and Zhang, 2008), are thought to be responsible for 
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Figure 4. Linear spike protein schematic 
Linear schematic of the spike proteins from MHV, MERS-CoV, and SARS-CoV. The 
cleavage site divides spike into S1 and S2, designated with the arrow logo. The receptor 
binding domain (RBD) is represented in yellow, and the receptor bound by each virus is 
indicated (CEACAM, Carcinoembryonic antigen-related cell adhesion molecule, DPP4, 
Dipeptidyl peptidase-4, ACE2, Angiotensin-converting enzyme 2). The fusion peptide 
inserts into the host membrane after triggering of fusion, and is represented in orange. 
Heptad repeats (HR) 1 and 2 are denoted in turquoise. The transmembrane domain (TM) 
exists within the viral membrane. 
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 the phenotypic differences of these viruses discussed in Chapter III (Figure 5). After 
cleavage of spike proteins between S1 and S2, they are able to mediate membrane fusion. 
This generally occurs after binding the cellular receptor, but some spike proteins also 
have certain pH or additional proteolytic activation requirements (Figure 6). Once fusion 
is triggered, the fusion peptide (FP) inserts into the cell host membrane and the protein 
refolds into its energetically favorable six-helix bundle formation. During this refolding 
event, the membranes of the virus and the cell are brought in proximity and fuse to one 
another. The viral genome is then able to enter the cell through the created fusion pore. In 
addition to initiating fusion between the virus and the cell, spike is also responsible for 
receptor binding, which influences tissue tropism, as virus will only bind to tissues 
expressing the necessary cellular receptor or receptors. Tissue tropism has been 
intensively studied, particularly for MHV (Belouzard et al., 2012).  
 
When spike is expressed on a cell surface in cleaved and fusogenic form, it can initiate 
cell-cell fusion and form giant, multinucleated cells termed syncytia (Figure 2). This has 
generally been thought to be a surrogate for fusion protein functionality; however, 
differences in membrane curvatures and viral envelope glycoprotein density are now 
thought to create differences between virus-cell fusion and the cell-cell fusion surrogate 
(Belouzard et al., 2012). The relationship between spike protein cleavage and cell-cell 
fusion capacities for coronaviruses, however, has been well established. MHV-A59 is 
able to generate large syncytia during infection. MHV-JHM has a more basic cleavage 
site than MHV-A59 such that it is more efficiently cleaved than MHV-A59. Interestingly, 
MHV-JHM replicates to a lower titer in cell culture 
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Figure 5. Spike is cleaved by different proteases in different CoVs 
For MHV-A59, spike is cleaved post assembly in the trans-Golgi by furin.  Spike on the 
surface of the virion is fusogenic, as well as any excess spike on the cell surface.  This 
virus can enter cells via direct fusion, and causes syncytia. For MHV-2, after entry via 
endocytosis, spike on the virion surface is cleaved by cathepsins.  Spike on the exiting 
virions is not cleaved, and syncytia do not form.  For SARS-CoV, it is thought that after 
entry via endocytosis, spike on the virion is cleaved by cathepsins.  If this was the only 
protease capable of cleaving spike, then no syncytia would be evident, however, syncytia 
are sometimes reported in vivo and in vitro. HAT, TMPRSS2, elastase, and thermolysin 
have been reported to cleave surface spike, and may be responsible for syncytia 
formation or for allowing virions to enter cells directly at the plasma membrane. 
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Figure 6. Coronavirus spike induces membrane fusion 
 
The spike fusion protein exists as a trimer at the surface of the virion. Upon interaction 
with the host cellular receptor (1), the S1 domain separates from S2 (2), allowing the 
fusion peptide (FP) to insert into the host cell membrane (3).  The peptide then folds into 
a lower energy state, the six-helix bundle (4), while fusing the membranes of the virus 
and cell together to form a fusion pore to allow viral genome entry (5). 
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(Navas and Weiss, 2003). Ablation of the furin cleavage site by introduction of an 
H716D mutation in spike of MHV-A59 impairs protein cleavage and significantly delays 
cell-cell fusion (Leparc-Goffart et al., 1997). Changes in fusion capacity as measured by 
cell-cell fusion have unclear effects on viral pathogenesis (Gombold et al., 1993). MHV-
A59 infected cells treated with furin inhibitor are unable to form syncytia, but can still 
infect new cells, likely through the same entry mechanism natively used by MHV-2 (de 
Haan et al., 2004).  
 
SARS-CoV spike (Figure 5) has been shown in culture to be dependent on the cathepsins 
for entry (Qiu et al., 2006; Simmons et al., 2005), though treatment with exogenous 
trypsin can trigger more efficient entry (Matsuyama et al., 2005; Simmons et al., 2004). 
Spike has been shown to be able to be cleaved in vitro by thermolysin and elastase 
(Matsuyama et al., 2005) and by the TMPRSS2 and HAT (TMPRSS11d) proteins, which 
associates with ACE2 on the surface of the cell (Bertram et al., 2011; Glowacka et al., 
2011; Kam et al., 2009; Shulla et al., 2011). SARS-CoV has been reported to form 
syncytia in cell culture, in animal models, and in human infections, but the syncytia are 
less frequent than during MHV infection (Ksiazek et al., 2003). 
 
Coronaviruses induce extensive rearrangement of cellular membranes 
Positive-strand RNA viruses induce extensive rearrangement of intracellular membranes 
to form replication complexes that are thought to recruit and concentrate critical viral 
replication materials, and provide protection from host immune surveillance (Figure 2). 
During infection with CoVs, cytoplasmic membranes reorganize into a complex network 
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of interconnected convoluted membranes and double-membrane vesicles contiguous with 
the ER that are critical for viral replication (Knoops et al., 2008). The CoV proteins nsp 
3, 4 and 6 contain defined transmembrane domains, and have been demonstrated to 
nucleate ER membrane alterations to form double-membrane vesicles (Denison and 
Perlman, 1986; Graham and Denison, 2006; Kanjanahaluethai and Baker, 2000; Lu et al., 
1995; Salonen et al., 2005). All nsps studied have been shown to localize to these 
complexes, but the exact method of their formation is yet to be determined. While several 
cellular proteins and pathways, including small GTPases and autophagy components 
(Prentice et al., 2004; Verheije et al., 2008), have been implicated in viral replication 
complex formation, little is known about the virus-host interactions required for cellular 
membrane reorganization.  
 
While much has been learned about virus-induced host cell modifications, little is known 
of the process of replication complex formation and how replication complexes change 
over time. It is known that nucleocapsid is associated with new sites of RNA synthesis, 
but also at sites of virus assembly in the ER-Golgi intermediate compartment (ERGIC) 
and Golgi distinct from sites of replication (Bost et al., 2001). The mechanisms by which 
replication complexes form, RNA synthesis occurs, and structural proteins and genomes 
transit to sites of virion assembly, however, remain unknown.  
 
The development of fluorescent reporter viruses, described in Chapter II, have allowed us 
to examine live, infected cells in real time to quantify the movement of the replication 
proteins thought to be responsible for these membrane changes. These reporter viruses 
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are fusions between firefly luciferase (FFL) or green fluorescent protein (GFP) and a 
replicase protein, either nsp2 or nsp3. These viruses are the first coronaviruses to express 
reporters from the replicase gene, and demonstrate the flexibility of the large coronavirus 
genome to tolerate extensive additions of foreign material. The fluorescent reporters can 
be used quantify the formation and evolution of replication complexes. The FFL versions 
of these viruses allow for quantification of the earliest stages of virus replication- 
specifically measurement of genome translation and amplification even early during the 
eclipse phase of replication.   
 
Live-cell imaging of MHV-infected cells utilizing these fluorescent reporter viruses 
revealed additional membrane rearrangements that had not been previously described for 
coronaviruses: constitutive membrane ruffling at the plasma membrane and the formation 
of long filopodia. Ruffling events were frequent and dynamic, and included two 
conformations of ruffles: peripheral ruffles that extended laterally from the cell and 
circular dorsal ruffles (Figure 7), which extended toward the observer, and closed with a 
“beggar’s purse formation” while retracting back into the cell. Cells ruffle for several 
different purposes, including immune surveillance, motility, to facilitate interactions with 
neighboring cells, and membrane ruffling is a hallmark of macropinocytosis (Swanson 
and Watts, 1995). Also, during these experiments, long filopodia extending from infected 
cells were first noticed. These, in addition to the previously described formation of 
syncytia during infection, make up a great amount of external surface membrane 
rearrangements that occur during infection in addition to the internal membrane 
rearrangements previously described during replication complex formation.  
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Figure 7. Evolution of membrane ruffles into macropinosomes 
During macropinocytosis, actin rearrangement at the plasma membrane creates 
membrane ruffles. These ruffles can be peripheral to the cell (main), or circular dorsal 
ruffles (inset). Peripheral ruffles often fold back onto themselves, trapping extracellular 
solutes and fluid, and fuse with the cell.  They are internalized as macropinosomes and 
mature within the endocytic pathway.  They can progress to the late endosome or 
lysosome, where their contents are degraded, or they can be recycled back to the plasma 
membrane surface. Circular dorsal ruffles close via a “Beggar’s purse closure,” named 
for its appearance, before being internalized. 
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Macropinocytosis 
Macropinocytosis is a cellular process morphologically defined by membrane extensions 
of outwardly polymerizing actin, or membrane ruffles. The presence of outwardly 
polymerizing actin, in addition to the large and pleomorphic size of the internalized 
vesicles, distinguish macropinocytosis from other types of endocytosis, such as clathrin-
mediated, caveolae -mediated, lipid raft-mediated, and from phagocytosis. Membrane 
ruffles often result in non-specific internalization of fluid cargo into large vesicles, or 
macropinosomes (Figure 7) (Hansen and Nichols, 2009; Kerr and Teasdale, 2009; 
Swanson and Watts, 1995). Macropinocytosis includes peripheral ruffles and 
lamellipodia at cell margins and circular dorsal ruffles on the dorsal cell membrane 
(Swanson, 2008). Macropinosomes rapidly traffic to the perinuclear region and acidify 
through the endocytic pathway as their fluid contents are absorbed into the cytosol 
(Swanson and Watts, 1995). Membrane ruffling is involved in cell migration, cell-cell 
interactions, environmental sampling, recycling of surface proteins and membranes, and 
delivery of bulk material to endosomes and lysosomes (Gu et al., 2011; Hewlett et al., 
1994; Nobes and Marsh, 2000; Orth and McNiven, 2006). While all cells are capable of 
macropinocytosis, it most commonly occurs in immune cells and cells that form 
endothelial and epithelial barriers. Macropinocytosis can be induced by exogenous 
growth factors or oncogenes (Hewlett et al., 1994; Veithen et al., 1996), by activation of 
tyrosine kinase receptors, including EGFR, phosphitdyl serine receptor, or α5 integrins, 
and involves many cellular factors including actin; Rho GTPases such as Cdc42 and 
Rac1 (Nobes and Hall, 1995); cellular kinases p21-activated kinase 1 (Pak1), 
phosphatidylinositol 3-kinase (PI3K), and protein kinase C (PKC) (Amyere et al., 2002); 
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and the Na+/H+ exchanger (Amyere et al., 2000; Araki et al., 1996; Dharmawardhane et 
al., 2000; Nobes and Marsh, 2000; Swanson and Watts, 1995; West et al., 2000) (Figure 
8). Macropinocytosis can be inhibited chemically by blocking key pathway regulators, 
most specifically by blocking the Na+/H+ exchanger, which is inhibited by ethyl isopropyl 
amiloride (EIPA) (Figure 9). This specificity exists because the Na+/H+ exchanger is not 
known to be involved in other endocytic pathways or in phagocytosis (Koivusalo et al., 
2010).  Macropinocytosis pathway members can also be inhibited by using siRNAs or 
dominant negative constructs. Fluid phase uptake can be measured or visualized by 
dextran or nanoparticle uptake and by markers of acidification and lysosomal targeting.  
 
In Chapter III, I report my results that define macropinocytosis during coronavirus 
infection and discuss why this process is important for viral replication.  
Macropinocytosis has been identified as an entry mechanism for several bacterial and 
viral pathogens including Salmonella enteritica, Neiserria gonorrhea, Rubella virus, 
Cocksackie B virus, Influenza, Ebola, Vaccinia, and HIV (Mercer and Helenius, 2009) 
(Figure 10). In each of these studies, membrane ruffling began with the addition of 
pathogen to cell culture and ceased after pathogen internalization. While subversion of 
the macropinocytosis pathway for pathogen entry is described, induction of constitutive 
macropinocytosis has been described only when induced by growth factors or oncogenes, 
or by dendritic cells surveying the environment (Mercer and Helenius, 2009). Our studies 
demonstrating constitutive macropinocytosis with MHV infection in cells that do not 
natively display macropinocytosis raise important questions about virus-host interactions 
responsible for macropinocytosis during infection, including whether the process is  
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Figure 8. Macropinocytosis activation pathway 
Macropinocytosis can be induced by activation of tyrosine kinase receptors (RTK), 
phosphitdyl serine receptors (PS), or α5 integrins, and involves many cellular factors 
including key kinases (blue ovals), GTPases (grey boxes), and adapter proteins (orange 
ovals).  Macropinocytosis can be inhibited chemically by blocking the Na+/H+ exchanger 
(NHE1), which is inhibited by ethyl isopropyl amiloride (EIPA), by inhibitors of the 
receptor, including gefitinib inhibition of EGFR, and through siRNA knockdown of 
pathway members (red boxes). Grb2- Growth factor receptor-bound protein 2, Rac1- 
Ras-related C3 botulinum toxin substrate 1, Cdc42- Cell division control protein 42 
homolog, FAK- Focal Adhesion Kinase, PI (3) K- Phosphatidylinositol 3-kinase, PI (5) 
K- phosphatidylinositol 5-kinase, PLC-phospholipase C, LIMK- LIM domain kinase 
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Figure 9. Testing for macropinocytosis 
A rubric for testing for macropinocytosis, including confirmation of membrane ruffling, 
demonstration of bulk fluid uptake, and dependence on macropinocytosis pathway 
members, including actin, Na+/H+ pump, GTPases, including Rac1 and Cdc42, and 
kinases, including Pak1, PI(3)K, and PKC. In order to demonstrate the dependence on 
these pathway members, chemical inhibitors or siRNA can be used. 
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Figure 10. Viruses use endocytosis for entry 
Endocytic mechanisms of eukaryotes are divided into two classes: pinocytosis for uptake 
of fluid and solutes, and phagocytosis (green box) for larger particles. Pinocytosis is 
further divided into those requiring dynamin for vesicle scission (light blue boxes), 
clathrin-mediated and caveolar, and those that do not, non-clathrin/caveolar, lipid raft 
mediated, and macropinocytosis. (purple boxes). Any of these pathways can be subverted 
for viral entry, and viruses may enter via more than one pathway. Viruses shown include: 
semliki forest virus (SFV); vesicular stomatis virus (VSV); human immunodeficiency 
virus 1(HIV-1); flaviviruses (Flavi); bunyaviruses (Bunya); influenzavirus (Influenza); 
adenovirus 2/5 (Ad2/5); simian virus 40 (SV40); BK virus (BK); human papilloma virus 
16 (HPV16); lymphocytic choriomeningitis virus (LCMV); polyomavirus (PVD); 
vaccina virus mature virion (VV MV); adenovirus 3 (Ad3); coxsackievirus B (CVB); 
herpes simplex virus 1 (HSV1); echovirus 1(EV1) and mimivirus (AMPV). Blue circles-
dynamin, dark blue lines-actin. 
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specifically induced and required by MHV for productive infection, and what viral and 
cellular pathways are involved in this process.  
 
Summary 
Coronaviruses are known to orchestrate the rearrangement of cellular membranes for 
replication through the formation of replication complexes. In contrast, prior to this work, 
little was known of coronavirus modifications of host cell plasma membranes. Live-cell 
imaging of cells infected with GFP-expressing MHV resulted in the observation that 
MHV infection is associated with profound rearrangements of the plasma membrane, 
including peripheral ruffles, circular dorsal ruffles, and the formation of long filopodia.  
 
Chapter II describes the engineering, recovery and use of MHV reporter viruses. Chapter 
III describes studies demonstrating that MHV induced ruffling events are 
macropinocytosis, which is important for efficient viral replication, likely as a 
mechanism of cell-cell spread. Chapter IV extends studies to MERS-CoV, demonstrating 
the development of antibodies against MERS-CoV nonstructural proteins and 
visualization of replication complexes in infected cells. Chapter V includes methods used 
for the experiments in this dissertation and Chapter VI discusses important implications 
of this work and the new questions it raises for continued study and discovery. Research 
into virus-cell interactions has a history of resulting in profound insights into normal cell 
biology. Coronaviruses appear to be profligate in their exploitation and modification of 
host cell membrane biology, both on the interior and the exterior of the cell. This work 
sought to investigate pathways long ago discovered by coronaviruses.  
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Chapter II: CORONAVIRUS REPLICASE-REPORTER FUSIONS PROVIDE 
QUANTITATIVE ANALYSIS OF REPLICATION AND REPLICATION 
COMPLEX FORMATION 
Introduction 
At the beginning of this dissertation, replicase proteins nsps 3, 4 and 6 were predicted to 
be involved in membrane modifications (Angelini et al., 2013) leading to formation of 
double membrane vesicles (DMVs), which are essential for replication. Each MHV nsp 
studied has been shown to localize to virus-induced DMVs and other modified host 
membranes, collectively referred to as replication complexes (RCs) (Gosert et al., 2002). 
While much has been learned about virus-induced host cell modifications, little is known 
of the process of replication complex formation or changes over time. It is known that 
nucleocapsid is associated with sites of RNA synthesis, but also at sites of virus assembly 
in the ERGIC / Golgi distinct from sites of replication (Bost et al., 2001). The 
mechanisms by which RCs form, RNA synthesis occurs, and nucleocapsids transit to 
sites of virion assembly, however, remain unknown. Coauthors of this publication 
corresponding to this chapter, Rachel Graham and Xiaotao Lu, generated the viruses used 
in these studies, the initial growth characterization, and performed the 
immunoprecipitation studies. Rachel Graham also assisted with some of the 
immunofluorescence images. I performed the majority of the immunofluorescence 
studies, and all of the competition assays, live-cell imaging, and comparative luciferase 
and replication studies. 
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To date, studies of CoV replication complex formation and evolution have involved 
immunofluorescence imaging of fixed cells using antibodies against native proteins 
(Brockway et al., 2003; Brockway et al., 2004; Sims et al., 2000; Snijder et al., 2006). 
For assessment of kinetics of replication, fluorescent and luminescent reporters have been 
expressed with replicase proteins either from expression plasmids, with reporter proteins 
replacing replication non-essential accessory ORFS, or with replicase protein-reporter 
fusions expressed in place of accessory ORFS (Bosch et al., 2004; Das Sarma et al., 
2002; de Haan et al., 2003; Fischer et al., 1998). Reporters also have been utilized within 
CoV replicon genomes (Hertzig et al., 2004). Studies with such constructs have provided 
insights into the function and interaction of replicase proteins and viral replication, as 
well as serving as reporters for studies of CoV inhibitors (Ge et al., 2007; Hertzig et al., 
2004; Roberts et al., 2006; Zhao et al., 2013). While these strategies have been useful for 
reporting on overall virus replication, they were not designed to test the expression or 
localization of specific proteins, nor were they designed to report replicase gene 
expression. A successful replicase reporter virus has been constructed for equine arteritis 
virus, an arterivirus with a genome size less than half that of MHV, with the insertion of 
EGFP in between nsp1 and nsp2 (van den Born et al., 2007). The capacity of the CoV 
replicase gene to accept foreign genes, however, is not known, nor has foreign gene 
insertion within the replicase gene of any replicating CoV been tested without 
compensatory deletion of viral genetic material. In this chapter, I defined quantitative 
translation of the MHV replicase gene and formation of replication complexes by using 
the reporters green fluorescent protein (GFP) and Firefly Luciferase (FFL) as in-frame 
fusions with viral replicase proteins nsp2 and nsp3. Nsp2 is a 65-kDa protein that has 
	  27	  
been shown to localize to CoV replication complexes, but is dispensable for virus 
replication in culture (Graham et al., 2005). Nsp3 is a 210-kDa protein that contains two 
essential proteases and other functional protein domains, and is required for both virus-
induced membrane modifications and virus replication (Angelini et al., 2013). Reporter 
fusions with nsp2 and nsp3 can be stably cloned into the MHV genome, permit efficient 
virus replication, target replication complexes, and provide the earliest indicators of 
MHV replication and direct measurement of replication complex formation. The results 
also demonstrate the capacity of the MHV genome to tolerate genomic expansion and 
identify sites for possible virus mediated expression of foreign proteins within the 
replicase polyprotein.  
 
Generation and recovery of MHV replicase reporter viruses 
Since nsp2 is dispensable for replication (Graham et al., 2005), I first tested the tolerance 
for reporter expression in place of deleted nsp2. This approach also was used since 
engineered genome length would not exceed WT MHV. Constructs were engineered in 
which enhanced green fluorescent protein (EGFP) (0.71 kb/26.8 kDa) or firefly luciferase 
(FFL) (1.65 kb/ 60.7 kDa) (Figure 11) replaced the nsp2 coding sequence. All constructs 
were initially designed with PLP1 specific cleavage sites at N and C termini of the 
reporter, based on the hypothesis that processing of the reporter from nsp1 and nsp3 
would be required for viability. Following electroporation of in vitro-transcribed genome 
RNA into BHK cells layered on permissive DBT cells, cytopathic effect (CPE) of 
syncytia was detected by 24 h post electroporation for both recombinant viruses. Media 
supernatants from electroporated cultures were used to infect fresh DBT cells and RNA  
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Figure 11. Generation and recovery of MHV replicase reporter viruses 
A. Schematic of MHV genome organization with ORF1a and ORF1b connected by 
ribosomal frameshift (RFS), and downstream structural / accessory ORFS: S-spike, E-
envelope, M-membrane, N-nucleocapsid. The ORF1ab polyprotein of MHV is shown, 
with nonstructural protein domains 1-16 (nsp). Papain-like proteinase domains PL1 and 
PL2 are indicated by grey and white boxes in nsp3. Nsp5 protease (3CLpro, Mpro) is 
indicated by the black box. Cleavages mediated by each domain are indicated by 
correspondingly colored arrowheads (CS1-cleavage site 1). Deletion is indicated by the Δ 
sign. B. Design of reporter fusion viruses. The top schematic shows WT-MHV-A59 
nsp1-3, with cleavage site residues P5-P2’ and cleavage sites marked by carets. The next 
schematics show previously described MHV-ΔCS2 (lacking P1-Gly at nsp2-3 cleavage 
site) and MHV-Δnsp2 with in frame deletion of nsp2 and functional engineered nsp1-
nsp3 cleavage site. GFP and FFL reporter gene insertions are indicated in grey. All 
confirmed functional cleavages indicated by grey arrowheads. MHV-Δ2-GFP/FFL3: 
MHV with deletion of nsp2 and fusion of GFP or FFL to nsp3. MHV-GFP/FFL2: MHV 
with addition of GFP or FFL as fusion to nsp2. 
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was harvested and amplified by RT-PCR for sequencing of the entire genome. Viral 
genome sequencing demonstrated retention of reporter genes without additional 
mutations in the genome. Passage of the P0 virus in culture demonstrated stability of the 
inserted GFP and FFL sequences for more than 5 passages (data not shown). This 
confirmed the capacity of MHV to accept proteins of differing size and structure in place 
of deleted nsp2. These viruses will be referred to as MHV-Δ2-GFP3 and MHV-Δ2-FFL3. 
I next investigated the capacity of the MHV replicase to accept additional genetic 
material into its genome without deletion of viral sequence. GFP and FFL were 
engineered between nsp1 and nsp2 while retaining all viral proteins. Since I sought to test 
whether reporter fusions with nsp2 could be recovered, the cleavage site between nsp1 
and the reporter was retained, but the cleavage site between the reporter and the nsp2 
amino terminus was deleted (Figure 11B). Both recombinant viruses were recovered, 
sequence confirmed, and passaged for > 5 passages with retention of the introduced 
sequences (data not shown). These viruses will be referred to as MHV-GFP2 and MHV-
FFL2. 
 
Polyprotein expression and processing in MHV replicase reporter viruses 
MHV-Δ2-GFP3 and MHV-Δ2-FFL3 mutant viruses were engineered with predicted 
functional cleavage sites at the nsp1 and nsp3 junctions. To define the processing of 
nsp1-reporter-nsp3 from the replicase polyprotein, DBT cells were infected with WT 
MHV, MHV-Δ2-GFP3, or MHV-Δ2-FFL3, radiolabeled, and proteins 
immunoprecipitated from lysates of infected cells with antibodies specific for nsps 1, 2, 
3, and 8 (Figure 12A). Immunoprecipitation of lysates from WT MHV-infected cells  
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Figure 12. Polyprotein expression and processing in MHV replicase reporter viruses 
A. DBT cells were infected with WT MHV, MHV-Δ2-GFP3 (G3), and MHV-Δ2-FFL3 
(F3). Radiolabeled proteins were immunoprecipitated by combined antibodies for nsp1, 
nsp3 and nsp8, and detected by fluorography. The molecular weight marker is indicated 
on the left. nsp3, nsp2-3, FFL-nsp3, and GFP-nsp3 are indicated in panel. m=mock B. 
DBT cells were infected with WT MHV, MHV-GFP2 (G2), and MHV-FFL2 (F2) as 
indicated by top labels and radiolabeled proteins were harvested by immunopreciptation 
and detected by fluorography. Antibodies used are indicated to the right or above. The 
dashed line represents the same gel with different exposure times, overnight on the left, 
and one week on the right. The molecular weight marker is indicated on the left. nsp2, 
GFP-nsp2, and FFL-nsp2 are indicated by white arrowheads. m=mock 
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detected nsps 1, 2, 3, 2-3, and 8. Immunoprecipitation of proteins from cell lysates of 
MHV-Δ2-FFL3 and MHV-Δ2-GFP3 infected cells detected both nsp1 and nsp8, but not 
nsp2, as expected. This indicated that processing was occurring at the junction between 
nsp1 and FFL/GFP, and that expression and processing of downstream proteins from the 
replicase polyprotein was intact. Immunoprecipitation with α-nsp3 in WT infected cells 
detected the 210-kDa nsp3 as well as the known nsp2-nsp3 intermediate precursor (275 
kDa). In contrast a 210-kDa-nsp3 protein was barely detectable following infection with 
MHV-Δ2-FFL3 and not detected from cells infected with MHV-Δ2-GFP3. Instead, α-
nsp3 antibodies detected a protein of ~271 kDa in MHV-Δ2-FFL3 infected cells (the 
predicted mobility of nsp3 plus FFL) and ~237 kDa in MHV-Δ2-GFP3 infected cells (the 
predicted mobility of nsp3 plus GFP). These results indicate that reporter molecules are 
efficiently processed at the nsp1-reporter junctions, but minimally or not processed at the 
engineered cleavage sites between the reporter and nsp3. This suggested that while P1’-
P5’ residues are required for cleavage, the context of P5-P1 also is important. The result 
serendipitously demonstrated that viable recombinant MHV could be engineered with a 
reporter fusion with the 210-kDa nsp3 protein.  
 
This outcome served as the rationale for design of the “second-generation” reporters, 
with a retained cleavage site between nsp1 and the reporter, and deletion of the cleavage 
site between the reporter and nsp2. For MHV-GFP2 and MHV-FFL2, 
immunoprecipitation of infected cell lysates with α-nsp1 and α-nsp8 detected the 
respective proteins. Antibodies against nsp2 detected the 65-kDa nsp2 in WT-infected 
lysates, but did not detect nsp2 in either reporter virus. Instead, α-nsp2 
	  32	  
immunoprecipitated proteins of 92 kDa or 126 kDa, consistent with the predicted sizes of 
GFP-nsp2 and FFL-nsp2 fusion proteins, respectively (Figure 12B). To confirm this, 
lysates were immunoprecipitated with α-GFP and α-FFL antibodies. The α-FFL detected 
a protein of identical mobility from MHV-FFL2 infected cells as detected by α-nsp2. The 
α-GFP immunoprecipitation of MHV-GFP2 infected lysates detected a protein with 
mobility slightly differing from that of α-nsp2, but consistent with a fusion of nsp2-GFP. 
The reason for the difference in mobility is not clear, but suggests different migrating 
forms of nsp2-GFP with different available epitopes recognized by α-nsp2 and α-GFP. 
The complete lack of nsp2 and detection of new proteins consistent with nsp2-GFP and 
nsp2-FFL strongly supported the expression of stable fusion proteins that are not cleaved 
during infection.  Overall, these results indicated that the recombinant viruses expressed 
the reporters as fusions with nsp3 or with nsp2.   
 
Replication of MHV-Δ2-GFP3, MHV-Δ2-FFL3, MHV-GFP2, and MHV-FFL2 
Previous work in our lab has shown that MHV-Δnsp2 replicates with similar kinetics to 
WT-MHV, but with a lower peak titer (Graham et al., 2005), while MHV mutants 
engineered to abolish cleavage site 2 between nsp2-nsp3 (MHV-ΔCS2) demonstrate a 
prolonged eclipse phase but ultimately achieve WT-like peak titer (Graham and Denison, 
2006). Finally, loss of cleavage between nsp1 and nsp2 has been demonstrated to result in 
decreased viral yield but WT-like timing of exponential replication (Gadlage and 
Denison, 2010). To test the effect of reporter fusions with nsp2 or nsp3, murine DBT 
cells were infected with MHV-Δ2-GFP3, MHV-Δ2-FFL3, MHV-GFP2, or MHV-FFL2 
viruses in direct comparison with WT-MHV, MHV-Δnsp2, and MHV-ΔCS2, with  
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Figure 13. Replication of MHV reporter fusion viruses 
DBT cells were infected with recombinant WT MHV, MHV-Δnsp2, MHV-ΔCS2, MHV-
Δ2-GFP3, MHV-Δ2-FFL3, MHV-GFP2, and MHV-FFL2 at an MOI of 1 PFU/cell. 
Supernatant was sampled at indicated times p.i., and titer determined by plaque assay. 
Titer reported is the mean of three replicates, +/- SD. 
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measurement of supernatant virus titer by plaque assay at multiple time points post 
infection (Figure 13). MHV-Δnsp2 replicated with 1-log10 impairment in viral titer but 
normal timing of exponential replication. MHV-ΔCS2 (nsp2-3 fusion) also replicated as 
previously reported, with delayed exponential replication but WT-like virus yield. MHV-
Δ2-GFP3 and MHV-Δ2-FFL3 replication resulted in a cumulative phenotype: A 4h delay 
in exponential replication similar to MHV-ΔCS2, and decreased viral yield similar to 
MHV-Δnsp2. In contrast, both MHV-GFP2 and MHV-FFL2 demonstrated replication in 
culture with exponential replication and viral yield similar to WT-MHV. This suggests 
that the replication phenotypes of MHV-Δ2-GFP3 and MHV-Δ2-FFL3 result from 
deletion of nsp2 and fusion of nsp2 with nsp3, not the insertion of foreign genes 
themselves. These results support previous studies from my lab proposing that cleavage 
at the nsp3 N-terminus is required for efficient onset of exponential replication (Graham 
and Denison, 2006). Similarly, the WT-like replication of MHV-GFP2 and MHV-FFL2 
further shows that it is cleavage at the C-terminus of nsp1 that is required for WT-like 
yield. Finally, the results demonstrate that expansion of the replicase gene and 
polyprotein can still allow for WT-like replication.  
 
Subcellular localization of nsp2 and nsp3 fusion reporters 
Next, the expression and localization of nsp2 and nsp3 reporter fusions in virus-infected 
cells were tested. DBT cells on glass coverslips were infected with reporter-expressing 
MHV at an MOI of 1 PFU/cell, fixed at 10 h p.i, stained for replicase proteins, and 
examined by confocal microscopy (Figure 14). DBT cells infected with WT MHV and 
stained with antibodies for nsp2, nsp3, nsp8, or membrane protein (M) demonstrated the  
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Figure 14. MHV nsp2 and nsp3 fusion reporters localize to replication complexes 
DBT cells were infected with WT MHV (A), MHV-Δ2-GFP3, MHV-Δ2-FFL3 (B), or 
MHV-GFP2 (C). At 10 h p.i. cells were fixed, stained with antibodies as indicated (α-
FFL, α-nsp2, α-nsp3, α-nsp8, α-M) and imaged by confocal microscopy. GFP was 
detected by native fluorescence. M – membrane protein. 
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established punctate cytoplasmic pattern of localization (Figure 14A). Cells infected with 
MHV-Δ2-GFP3 or MHV-Δ2-FFL3 also exhibited punctate, perinuclear cytoplasmic 
localization of reporter molecules by native fluorescence (GFP) or by IF with a-FFL. 
GFP and FFL both colocalized with nsp8 (Figure 14B), a replicase protein known to 
localize to replication complexes, but were distinct from M, which localizes to sites of 
viral assembly in the ERGIC / Golgi (GFP, Figure 14A, FFL, data not shown). The 
punctate nature of reporter localization suggests a mechanism for specific targeting to 
replication complexes. In addition, these results demonstrate that GFP fluorescence is 
intact when the reporter is fused to the N-terminus of nsp3. DBT cells infected with 
MHV-GFP2 (Figure 14C) also exhibited punctate, perinuclear cytoplasmic localization, 
and colocalized with nsp2 and nsp8, again demonstrating specific targeting to replication 
complexes and indicating that native fluorescence is intact in the nsp2-reporter fusion 
protein. 
Competitive fitness of WT MHV vs. MHV-GFP2 
Since MHV-FFL2 and MHV-GFP2 demonstrated WT-like kinetics during replication in 
culture, I investigated whether there was a fitness cost associated with introduction of a 
foreign protein in the replicase polyprotein. Cells were infected with WT MHV or MHV-
GFP2 alone, or at WT MHV: MHV-GFP2 ratios of 1:1, 1:10, or 10:1 at a combined MOI 
of 0.1 PFU/cell, followed by 10 passages of supernatant onto fresh flasks of DBTs. GFP 
expression was compared with expression of replicase protein nsp8 to determine the 
relative competitiveness of the MHV-GFP2 virus. DBT cells seeded on glass coverslips 
were infected with P1, P3, and P10 passages of each combination of viruses for 8 hours. 
Following immunostaining for nsp8, coverslips were imaged and scored for nsp8  
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Figure 15. Competitive fitness of WT-MHV and MHV-GFP2 
DBT cells were infected with WT MHV or MHV-GFP2 alone or at 1:1, 1:10, or 10:1 
ratios of WT-MHV:MHV-GFP2. DBT cells on glass coverslips were infected at an MOI 
of 1 PFU/cell with P1, P3, and P10 passages of each combination. At 8 h p.i., cells were 
fixed and imaged for nsp8 (red) and GFP (green). Cells containing green (MHV-GFP2) 
or red (WT MHV or MHV-GFP2) replication complexes were scored. Thirty images 
from two independent experiments were photographed and scored for cells infected only 
with WT MHV or only with MHV-GFP2, while for the WT:G2 1:1, 1:10, and 10:1 
samples, 50 images from two independent experiments were scored. 
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(indirect immunofluorescence-red) and GFP (native green fluorescence). At all passages, 
WT MHV-infected cells exhibited only nsp8 (red) signal, while MHV-GFP2-infected 
cells demonstrated colocalized nsp8 (red) and native GFP in all cells (Figure 15). In 
competition experiments, at P1 MHV-GFP2 infected cells were detected, but not at levels 
equivalent to the input ratios. By P3 to P10, even when a 10-fold advantage was given to 
MHV-GFP2, the recombinant virus could not compete with WT. Thus, while GFP as a 
fusion with nsp2 had no effect on replication as measured by plaque assay, the insertion 
of the gene was associated with a fitness cost compared to WT virus. 
GFP-nsp2 allows quantitation of replication complex formation in live cells 
I tested whether reporter-nsp fusions could be used to track the quantity and movement of 
these proteins within a single infected cell over time. DBT cells cultured in glass-
bottomed dishes were infected with MHV-GFP2 and at 5 h p.i., were imaged in a 37°C 
live imaging chamber incubator on a wide-field fluorescence microscope. Images were 
collected in the differential interference contrast (DIC) and green filter sets every thirty 
seconds for 2.5 hours from the same field (Figure 16). Every tenth image was analyzed 
for corrected total cell fluorescence (CTCF) by selecting the cell as the region of interest 
(ROI) and correcting for the background within each individual image (Burgess et al., 
2010). Green fluorescence is evident from the first frame and the CTCF nearly triples in 
value throughout infection until it peaks at 6.75 h p.i. At the conclusion of imaging at 7.5 
h p.i., CTCF has decreased by 30% from the peak value. Throughout the collection of 
images, green fluorescence is localized perinuclearly, with both increasing numbers and 
intensity of GFP foci from 5 to 7.5 h p.i. The increase in fluorescence intensity during 
infection indicates that more copies of GFP-nsp2 are being produced and accumulating,  
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Figure 16. MHV-GFP2 quantitation of replication complex formation in live cells 
 
A. DBT cells on glass bottom culture dishes were infected with MHV-GFP2 at an MOI 
of 1 PFU/cell. At 5 h p.i., dishes were transferred to the 37°C chamber incubator, with 
imaging of DIC and GFP every 30 seconds for 2.5h. Individual frames were used to 
generate this panel. The video sequence corresponding to this figure can be seen as Fig. 
S1. B. Corrected total cell fluorescence (CTCF) was measured for the cell utilizing 
ImageJ. CTCF was calculated for every ten frames and plotted over time. Data shown is 
calculated from three independent infected cells. 
 
 
	  40	  
as each copy of nsp2 is fused only to one fluorescent molecule, in contrast to indirect 
fluorescence where multiple fluorescent molecules have the capacity to bind to one viral 
protein. These results indicate that MHV-GFP2 and MHV-Δ2-GFP3 reporter viruses can 
be used to directly measure the progression of RC formation in real time in single 
infected cells, as well as tracking the localization and movement of nsp2 and nsp3 over 
time.  
 
FFL-nsp2 is a highly sensitive quantitative measure of genome translation	  
Translation of input genome RNA is the first step in virus replication, and ORF1a–
encoding nsp2 and nsp3 domains, is translated 100% of the time. I hypothesized that this 
would allow translation of luciferase to provide an earlier marker of viral replication. I 
inquired whether FFL expression as fusions with nsp2 or nsp3 could quantitatively 
measure replication, and if so, whether it was as sensitive as virus titer. DBT cells were 
infected with MHV-FFL2 or MHV-Δ2-FFL3 viruses at an MOI of 1 PFU/cell, 
supernatants collected for plaque assays, and cells harvested for luciferase assays at 
multiple times post infection (Figure 17). MHV-FFL2 and MHV-Δ2-FFL3 both 
replicated as expected with MHV-Δ2-FFL3 demonstrating delayed exponential 
replication and decrease in virus yield compared with MHV-FFL2. Luciferase activity 
(yield in relative light units – RLU) for MHV-FFL2 showed signal >3 log10 higher than 
the corresponding titer for the at 4 h p.i., while increasing in signal over time. At 8 h p.i., 
measurements of luciferase activity and titer were very similar. MHV-Δ2-FFL3-infected 
cells also demonstrated a >3 log10 increase in FFL signal compared to viral titer at 4 h 
p.i., but this increased signal was retained until 16 h p.i. Most importantly, for both  
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Figure 17. MHV-FFL2 and MHV-Δ-FFL3 are quantitative measures of replication 
DBT cells were infected with MHV-Δ2-FFL3 or MHV-FFL2 at an MOI of 1 PFU/cell in 
replicate wells. At indicated times h p.i., supernatant was collected for measurement of 
virus titer by plaque assay and cells harvested for measurement of FFL activity. Titer 
(PFU/solid) and luminescence (RLU/dotted) are plotted. Data is represented as the mean 
+/- SD of three replicates. 
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viruses, FFL activity was detected earlier and 100 fold greater than virus titer during 
eclipse phase. The amplification trend for MHV-FFL2 luminescence mirrors replication, 
as does the trend for MHV-Δ2-FFL3, suggesting that this assay can serve as a robust 
early surrogate for viral replication. Further, the results demonstrate that replicase gene 
translation is occurring continuously and genome used as a translational template is being 
amplified, even in virus with delayed exponential increase in virus titer. These results 
establish that expression of the FFL reporter from the MHV replicase serves as a 
sensitive, quantitative marker of replicase polyprotein translation and as a discriminating 
indicator of viral replication. They also suggest that it may be possible to uncouple 
measurement of genome translation and genome replication from measurement of 
infectious virus, and might act as a much earlier biological marker for studies of virus 
inhibition or studies or constitutive or conditional mutations. 
 
Discussion 
In this chapter, I demonstrated that the CoV genome is capable of tolerating large 
substitutions or additions of foreign genetic material within the replicase protein as in-
frame protein domains. Further, I showed that fusion of reporters to replicase proteins is 
tolerated in efficiently replicating virus, allowing quantitative assessment of multiple 
stages in the virus life cycle. Specifically, the studies show that measurement of viral 
replication by using FFL can be a highly sensitive, early and powerful surrogate for 
genome replication and that GFP fusions with nsp2 and nsp3 can allow for quantitative 
assessment of replication complex formation and evolution during the course of infection. 
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Finally, the results show that insertion of very different proteins are tolerated at each of 
these locations.  
 
Most studies of CoV replication using addition of reporters have involved substitution of 
accessory ORFs. These have been used as general indicators of overall viral replication, 
mostly for testing inhibitors or attenuation of replication (Curtis et al., 2002; de Haan et 
al., 2003; Fischer et al., 1998; Ge et al., 2007; Hertzig et al., 2004; Kilianski et al., 2013; 
Pfefferle et al., 2011; Roberts et al., 2006; Zhao et al., 2013). However, these strategies 
are limited as direct indicators of genome replication since they require subgenomic 
mRNA transcription for expression of the engineered reporters or are not contained 
within infectious virus. While reporters expressed from downstream ORFs are valuable 
as indicators of overall viral replication, they cannot distinguish genome replication from 
subgenomic mRNA transcription.  Reporters also have been employed for analysis of 
coronavirus host interactions and cell biology. Specifically, expression of nsp2-reporter 
or nsp4-reporter fusions as substitutions of MHV ORF4 or HE have been described and 
used to define localization and movement of nsps (Gadlage et al., 2008; Hagemeijer et 
al., 2011; Hagemeijer et al., 2010). While informative, these studies are limited in their 
interpretation by nsp expression from non-native locations in the genome. Previous work 
in the Denison lab has shown that alternative expression of nsp2 can be detrimental to 
replication, even when expressed as a duplication with native nsp2 (Gadlage et al., 2008). 
These results suggest that the context of nsp2 location in the polyprotein is important for 
its interaction with adjacent replicase proteins. Although nsp2 is dispensable for 
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replication (Graham et al., 2005), altering expression by deletion or cleavage site 
alteration impacts replication and fitness.  
 
The observation that GFP or FFL fusions with nsp2 had no detectable effect on the MHV 
replication cycle in culture was surprising and suggests significant flexibility in this 
region of the polyprotein for additional genetic information. A recent study of the 
evolution of the genomes of nidoviruses from the small arteriviruses (~15 kb) to the 
largest coronaviruses (up to 32 kb) proposed that proto-CoVs emerged due to 
incorporation of a cassette of proteins including the proofreading exonuclease in nsp14, 
which allowed more stability of larger genomes (Lauber et al., 2013). It also was 
proposed that increased genetic robustness to mutations also was required for genome 
expansion and increased complexity. This study supports that argument, with 
incorporation of FFL expanding the MHV genome by ~5.3%. The virus can be recovered 
at P0 and P1 with high titer stocks for use in vitro and in vivo and the FFL coding 
sequence is maintained for at least 5 passages. However, introduction of GFP as an nsp2 
fusion results in a fitness cost during direct competition with MHV. It will be interesting 
to see if this fitness cost is similar for FFL or other foreign genes. It will also be of 
interest to see whether foreign genes are retained over long passage in absence of 
competition, or if the subtle fitness cost results in selection against the foreign sequences 
in the long term.  
 
The implications of stable replicase nsp-reporter fusions are significant for several 
reasons. It has not previously been possible to directly quantitate translation of the CoV 
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replicase/ transcriptase polyproteins in infected cells. CoV ORF1a expresses ~495 kDa 
polyprotein (pp1a). Translation of ORF1b, which encodes critical replication enzymes 
including nsp12-RdRp and nsp14-ExoN, requires a ribosomal frameshift between nsp10 
and nsp12. In vitro studies have suggested frameshift efficiencies ranging from 10-40% 
(Somogyi et al., 1993). Dual luciferase systems have been used to examine structures and 
sequences in this region, however this has never been tested utilizing infectious virus 
(Plant et al., 2005; Plant et al., 2013). Expression of different quantitative reporters from 
ORF 1a and ORF1b could allow direct testing of timing and stoichiometry of replicase 
polyprotein translation. Our lab has recently recovered recombinant viruses expressing 
GFP as a fusion with nsp14 (unpublished results), providing encouraging evidence that 
ORF1b reporter expression is possible. The early exponential signal from FFL-nsp2 is 
consistent with rapid amplification of genome RNA prior to virus assembly and release, 
and thus may be an early and sensitive reporter for studies of inhibitors of virus 
replication.  Similarly, it has not previously been possible to track the expression and 
localization of replicase proteins from their native locations in the genome. Native 
expression of fluorescent reporters fused to replicase proteins creates the opportunity to 
track replication complex formation in real time in a single cell, without potential 
artifacts due to cellular fixation for immunofluorescence or due to altered expression 
from subgenomic mRNAs or exogenous plasmids. These results suggest that it may be 
possible to engineer reporter-fusions with multiple replicase proteins for testing and 
visualization of protein-protein and protein-membrane interactions in live cells.  
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Chapter III: CORONAVIRUSES INDUCE CONTINUOUS, ENTRY-
INDEPENDENT MACROPINOCYTOSIS 
Introduction 
At the beginning of this dissertation, coronaviruses were known to initiate extreme 
rearrangements of host cell membranes to promote replication. These membrane 
structures on the interior of the cell include double membrane vesicles and convoluted 
membranes (Perlman and Netland, 2009). Modified membranes are thought to 
concentrate critical viral replication materials and to provide protection from host 
immune surveillance (Knoops et al., 2008). While several viral proteins, specifically nsps 
3, 4, and 6, are thought to orchestrate this process in addition to other cellular proteins 
and pathways, including small GTPases and autophagy components (Prentice et al., 2004; 
Verheije et al., 2008), little is known about virus-host interactions required for cellular 
membrane reorganization. In addition to these internal membrane organizations, 
coronaviruses modify the plasma membrane during several stages of their life cycle, 
including entry via direct membrane fusion at the plasma membrane or endocytosis and 
non-lytic exocytosis. For several CoVs, including murine hepatitis virus (MHV) and 
SARS-CoV, cell surface expression of proteolytically mature spike protein mediates 
interactions with receptors on adjacent cells, resulting in cell fusion and syncytia 
formation. Expression of spike alone may be sufficient for formation of syncytia 
(Belouzard et al., 2009; Bertram et al., 2011). Syncytia formation is a well-described 
cytopathic effect for many viruses in cell culture or in animal model systems, and has 
been suggested to increase viral cell-cell spread (Yamada et al., 2009). However, for 
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coronaviruses, syncytia formation has not been tested for a role in replication or cell 
spread.  
 
A live-cell imaging experiment at the beginning of this dissertation project revealed an 
intriguing and somewhat unexpected phenotype. Late during infection with MHV, the 
plasma membrane underwent extreme morphologic changes with the extension of 
filopodia, peripheral ruffles, circular dorsal ruffles, and the internalization of large and 
pleomorphic vesicles that collected toward the nuclei of the cell. Plasma membrane 
ruffling has been previously described to be a defining characteristic of 
macropinocytosis. The initial live-cell imaging studies were performed by Mark Denison 
and repeated many times by Chris Peek and me.  I also had some assistance with the 
BSL3 work to complete the experimental portion of the SARS-CoV studies by Michelle 
Becker and Clint Smith, though all of the data was analyzed by me. Chris Peek assisted 
with the development of the nanoparticle uptake assay and methods for image analysis.  I 
generated all other experimental data. 
 
In this chapter, I demonstrate that, in addition to internal membrane rearrangements, 
CoVs also induce plasma membrane changes consistent with macropinocytosis. 
Macropinocytosis is a type of endocytosis, morphologically defined by the presence of 
membranous extensions of outwardly polymerizing actin, termed membrane ruffles. 
Membrane ruffles non-specifically surround and internalize fluid cargo into large 
vesicles, or macropinosomes (Hansen and Nichols, 2009; Kerr and Teasdale, 2009; 
Swanson and Watts, 1995). Membrane ruffling is involved in cell migration, cell-cell 
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interactions, environmental sampling, recycling of surface proteins and membranes, and 
delivery of bulk material to endosomes and lysosomes (Gu et al., 2011; Hewlett et al., 
1994; Nobes and Marsh, 2000; Orth and McNiven, 2006). While all cells are proposed to 
be capable of macropinocytosis, it is generally associated with immune cells that monitor 
the environment for pathogens, as well as for apoptotic body clearance (Henson et al., 
2001). Macropinocytosis is usually transient, but is constitutive in cells transformed by 
the SRC oncogene (Amyere et al., 2002). Macropinocytosis may be initiated by 
activation of the epidermal growth factor receptor (EGFR) and involves signaling though 
GTPases and kinases including Rac1, Cdc42, and Pak1. Further, macropinocytosis 
requires sodium hydrogen exchangers (NHE) and thus is specifically inhibited by 5-(N-
Ethyl-N-isopropyl)-amiloride (EIPA) (Mercer and Helenius, 2009, 2012). 
Macropinocytosis has been identified as an entry mechanism for several pathogens 
including Salmonella enteritica, Neiserria gonorrhea, cocksackie B virus, influenza 
virus, Ebola virus, vaccinia virus, Nipah virus, and HIV (Mercer and Helenius, 2009; 
Pernet et al., 2009). In each of these studies, membrane ruffling or blebbing is induced by 
addition of the pathogen to cell culture, and membrane modifications cease after 
pathogen internalization. To date, no role for macropinocytosis other than entry has been 
described as a host-pathogen interaction of viruses or bacteria.  
 
In this study, I show that cells infected with CoVs MHV or SARS-CoV induce 
macropinocytosis with well-defined characteristics: membrane ruffling and extensive 
filopodia formation, large vesicle internalization, increased bulk fluid uptake, actin 
polymerization, dependence on signaling through Cdc42, Rac1, and Pak1, and sensitivity 
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to EIPA. MHV-induced macropinocytosis is continuous once initiated ≥ 4 hours post 
infection, significantly after viral entry is completed. Replicating virus is required for 
induction of macropinocytosis, and inhibition of macropinocytosis impairs viral titer and 
cell-cell fusion. MHV-induced macropinocytosis requires fusogenic spike glycoprotein, 
and is dependent on EGFR activation. The results support a role for CoV-induced 
macropinocytosis in cell fusion and virus cell-cell spread, representing novel exploitation 
of macropinocytosis machinery for virus use.  
 
Infection with MHV or SARS-CoV induces continuous membrane ruffling 
During live-cell imaging of murine hepatitis virus (MHV)-infected cells, we observed 
that MHV-infected cells displayed plasma membrane ruffling and extensive filopodia. 
We therefore examined the etiology and role of plasma membrane ruffling during CoV 
infection. Murine delayed brain tumor (DBT) astrocytoma cells were infected with MHV 
strain A59 (MHV-A59) expressing GFP as a fusion with the replicase protein nsp3 
(Freeman et al., 2014) and cells were imaged continuously from 4 to 12 hours post 
infection (h p.i.), until the monolayer was entirely involved in syncytia or was lost 
(Figure 18A and Figure 19). Cell infection was confirmed both by the presence of GFP-
nsp3 at replication complexes, and by syncytia formation, a characteristic cytopathic 
effect of MHV infection. Membrane ruffling on multiple edges of the cell was noted to 
begin after 5 h p.i., similar to the time of appearance of GFP-nsp3 fusion proteins at 
replication complexes and was continuous throughout infection. The plasma membrane 
changes were extensive, and included lamellipodia, filopodia, peripheral dorsal ruffles, 
and circular dorsal ruffles (Figure 18A, Figure 19).  The membrane ruffling associated  
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Figure 18. Infection with MHV or SARS-CoV induces membrane ruffling and 
vesicle internalization 
A) DBT cells were infected with MHV-Δ2-GFP3, at an MOI of 1 PFU/cell and imaged 
from 4-12 h p.i. Small panels to the right correspond to the white box and are enlarged to 
show detail. Green fluorescence indicates nsp3. Black arrowheads denote vesicles. White 
arrowheads follow the evolution of a vesicle over time. B) Vesicle diameter was 
measured from 5 movies of infected cells, MOI=1 PFU/cell, n=386 vesicles. C-D) DBT 
cells were infected with MHV-A59 at an MOI of 1 PFU/cell for 8 h.  DBT-hACE2 cells 
were infected with SARS-CoV at an MOI of 0.1 PFU/cell for 24 h. Cells were fixed with 
10% formalin and stained for F-actin (green). Arrow denotes ruffle (C). Every third 
infected (or mock) cell was imaged and scored for ruffling by 3 blinded reviewers. Data 
is represented as averages +/- SEM of two replicates in duplicate. Significance was 
assessed using one-way ANOVA with Dunnett’s post-hoc test. n≥30 fields per replicate. 
*p<0.05. 
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Figure 19. MHV-infected cells form long filopodia 
DBT cells transfected with a GFP-expressing plasmid were infected with MHV-A59 at 
an MOI of 1 PFU/cell for 6 h and visualized using live cell imaging for several hours.  
This image is a series of stills from a video demonstrating that infected cells form long 
filopodia that create contacts with neighboring cells, leading to their fusion with the 
original infected cell. Time stamps are in minutes. 
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with infection frequently resulted in the internalization of large vesicles. We measured 
the diameters of 386 vesicles from five live imaging movies of MHV-infected cell 
monolayers. Vesicle diameters ranged from 0.49 µm to 4.14 µm with a mean diameter of 
1.45 µm (Figure 18B). This large vesicle diameter was similar to that reported for 
macropinosomes in multiple systems, and much larger and more variable in size than that 
of endosomes generated by other forms of endocytosis (Swanson, 2008). In addition to 
ruffling and vesicle formation, MHV-infected cells reproducibly manifested long 
filopodia that extended from infected cells and contacted distant cells resulting in fusion 
at the point of contact and subsequent recruitment of cells into syncytia (Figure 19). 
 
To determine the composition of these membrane ruffles, we tested for the presence of 
actin by staining MHV-infected, fixed cells with fluorescent phalloidin (Figure 18C-D). 
Because macropinocytosis has not previously been reported in CoV-infected cells, we 
tested whether it occurred during infection with other CoVs, specifically SARS-CoV. To 
control for variations in cell type, DBT cells expressing the human ACE2 receptor for 
SARS-CoV (DBT-hACE2) (Sheahan et al., 2008) were infected with SARS-CoV for 24 
h and compared with mock-infected DBT-hACE2 cells, mock-infected DBT cells, and 
MHV-infected DBT cells. Cells were fixed, stained with fluorescent phalloidin, imaged, 
and the cells were scored for ruffling (Figure 18C). Both MHV-and SARS-CoV-infected 
cells demonstrated a significantly increased number of cells exhibiting membrane ruffles 
compared to mock-infected cells (Figure 18D). Cellular ruffling was also confirmed in 
MHV-infected HeLa-R and BHK-R (each expressing CEACAM1, the MHV receptor), 
and 17Cl1 cells (data not shown). 
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Infection with MHV or SARS-CoV induces bulk fluid uptake consistent with 
macropinocytosis 
A hallmark of macropinocytosis is bulk fluid uptake from the surrounding environment. 
To test whether CoV-infected cells were inducing bulk fluid uptake, we used Nile Red 
neutral polystyrene nanoparticles with a diameter of 800 nm as markers, since their size 
is excluded from all endocytic pathways except macropinocytosis. MHV-infected DBT 
cells (Figure 20A-B) and SARS-CoV-infected DBT-hACE2 cells (Figure 20B) were 
incubated with nanoparticles for the last 3 h of infection. Cell monolayers infected with 
either MHV or SARS-CoV demonstrated a significantly higher percentage of cells with 
internalized nanoparticles than mock-infected cells (Figure 20B). Macropinocytosis has 
been described as a means of pathogen entry in several different systems. However, since 
our data suggested MHV-induced ruffling was occurring much later during infection, we 
next determined the timing of bulk fluid uptake during MHV infection. Cells were mock-
infected or infected with MHV, then incubated with nanoparticles for two-hour intervals 
beginning at infection, and fixed immediately afterwards (Figure 20C). Significantly 
increased nanoparticle uptake was first detected between 4-6 h p.i. and was also 
prominent at 6-8 h p.i., indicating that increased fluid phase uptake initiates at 4 h or later 
post-entry and continues through the remainder of infection. This result was consistent 
with our visual and quantitative measurement of ruffling and vesicle formation. Because 
nanoparticle uptake occurred late during infection, we next tested whether replicating 
MHV was required to induce bulk fluid uptake. Cells were mock-infected, infected with 
MHV, or incubated with an equal concentration of UV-inactivated or heat-inactivated 
MHV and incubated with nanoparticles for two-hour intervals, beginning at infection  
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Figure 20. Infection with MHV or with SARS-CoV induces nanoparticle 
internalization that requires replicating virus 
A-B) DBT cells were infected with MHV-A59 at an MOI of 1 PFU per cell for 8 h. DBT-
hACE2 cells were infected with SARS-CoV at an MOI of 0.1 PFU/cell for 24 h. 
Nanoparticles were added 3 h prior to fixation, and cells washed, fixed, stained, and 
imaged. Arrows denote nanoparticles (red). DAPI (blue), nsp8 (green). B) Data is 
represented as the mean +/- SEM of two replicates in duplicate. n≥30 fields per replicate. 
C) Cells were mock-infected or infected with MHV, UV-inactivated MHV (UV), or heat-
inactivated MHV (HI) at an MOI=1 PFU/cell (or equivalent volume for noninfectious 
virus) for 8 h. Nanoparticles were added in 2h increments, as designated, and cells were 
washed, fixed, stained and imaged. Data is represented as the mean +/- SEM of two 
replicates in duplicate. D) DBT cells on a glass- bottom dish were infected with DiI 
labeled MHV (white arrows) at an MOI of 25 PFU/cell, incubated at 4°C for 30 m, and 
imaged in the 37°C chamber incubator for 1 h. Time is in minutes:seconds. Virus fusion 
with the cell was observed, but membrane ruffling was absent. A representative image is 
shown of triplicate experiments. Significance was assessed using one-way ANOVA with 
Dunnett’s post-hoc test. **p<0.005, ***p<0.0001. 
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 (Figure 20C). UV-inactivated MHV did not result in increased nanoparticle uptake, 
suggesting that surface receptor interactions were insufficient to induce 
macropinocytosis. Heat-inactivated MHV also did not cause nanoparticle internalization, 
suggesting that the membrane ruffling phenotype observed was not a cellular response to 
foreign particles. In addition, in order to confirm that macropinocytosis is not utilized for 
entry of coronaviruses, we labeled virions with DiI and added them to DBT cells grown 
on a glass-bottom dish at a high MOI of 25 PFU/cell (Figure 20D). Virions were 
adsorbed for 30 minutes at 4°C to synchronize the infection before transferring them to 
the 37°C chamber incubator surrounding the microscope. Cells were then live-imaged for 
1 hour. While we did visualize viruses entering cells at the plasma membrane, we did not 
observe any evidence of cellular membrane ruffling at the site of entry or elsewhere on 
the cell. Thus, virus infection is required for induction of bulk fluid uptake, and MHV-
induced macropinocytosis is not associated with virus entry. 
 
MHV-induced macropinocytosis is dependent on the classical macropinocytosis 
pathway 
We next determined whether MHV-induced macropinocytosis required known mediators 
of cellular macropinocytosis. We selected Rac1, Cdc42, and Pak1 from the classical 
macropinocytosis pathway for siRNA inhibition. Inhibition of RhoA was chosen as a 
negative control, since it is not associated with macropinocytosis. For each siRNA 
molecule, target knockdown ≥80% was confirmed by immunoblot (Figure 21A, B). 
Transfection efficiency was tested with siRNA-AllSTARS-GFP and found to be >96% 
(data not shown). Inhibition of Pak1, Cdc42, and Rac1 resulted in significantly decreased  
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Figure 21. Nanoparticle uptake during MHV infection is dependent on classical 
macropinocytosis pathway members 
A-B) Cells were reverse transfected with siRNA for 72 h and protein knockdown was 
confirmed by immunoblot (A) and standardized to GAPDH (B). Scramble (sc) and 
siRNA (si)-treated samples are from the same gel for each protein.  RhoA and Pak1 are 
from discontinuous lanes denoted by dashed lines. Data are represented as the means +/- 
SEM in triplicate. C) Cells were reverse transfected for 68 h and infected with MHV for 
8 h. Nanoparticles were added during the final 3 h, cells were washed, fixed, stained, and 
imaged. Data are represented by averages +/- SEM of two replicates in duplicate, n≥30 
fields per replicate. D) 12 h toxicity was assessed for EIPA with CellTiter Glo. E) Cells 
were mock-infected or infected with MHV at an MOI of 1 PFU/cell for 8 h with no drug, 
DMSO, or 40 µM EIPA. Nanoparticles were added during the final 3 h of infection. Cells 
were washed, fixed, stained, and imaged, and the percentage of cells with internalized 
nanoparticles was calculated. Data are represented as averages +/- SEM of two replicates 
in duplicate. Significance was assessed using one-way ANOVA with Dunnett’s post-hoc 
test.  *p<0.05, **p<0.01, ***p<0.0001. 
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nanoparticle internalization following MHV infection, while nanoparticle uptake was 
unchanged in cells transfected with a scrambled siRNA or with siRNA targeting RhoA 
(Figure 21C). These results demonstrate that MHV-induced macropinocytosis signals 
through a known cellular macropinocytosis pathway.  
 
EIPA is an inhibitor of sodium-hydrogen exchangers (NHE) and is the most specific 
known chemical inhibitor of macropinocytosis. Other endocytic pathways do not use 
NHE and are not impacted by treatment (West et al., 1989). We compared nanoparticle 
internalization in MHV-infected and uninfected cells treated with nontoxic doses of EIPA 
(Figure 21D) or with DMSO, the vehicle control. EIPA-treated, infected cells internalized 
significantly fewer nanoparticles than DMSO-treated, infected cells (Figure 21E). Thus, 
all data collected to this point are consistent with the hypothesis that MHV is inducing 
macropinocytosis during infection: membrane ruffling, bulk fluid uptake, dependence on 
classical pathway members, and sensitivity to EIPA. 
 
Inhibition of macropinocytosis impairs MHV replication 
We next tested the requirement for macropinocytosis during MHV replication (Figure 
22). We utilized siRNA knockdown of Pak1, treatment with C. difficile toxin A (CdtA), 
or treatment with EIPA and determined the effect on viral replication. CdtA decreases 
ADP-ribosylation of Rho family proteins, including Rac1, RhoA, and Cdc42, and thus we 
used this as an independent mechanism to confirm the relationship between 
macropinocytosis and viral replication (Just et al., 1995). Inhibition of Pak1 with siRNA  
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Figure 22. Inhibition of macropinocytosis impairs MHV replication 
A) Cells were reverse transfected for 68 h and infected with MHV for 12 h. Supernatant 
samples were titered via plaque assay. Data are represented by averages +/- SEM of two 
replicates in duplicate. B) 12 h toxicity was assessed for C. difficile toxin A (TcdA) with 
CellTiter Glo. C) Cells were treated with HEPES buffer, or 10 nM TcdA for 2 hours prior 
to infection with MHV-A59 at an MOI of 1 PFU/cell. Viral titer was measured at 10 h 
p.i. Data are represented by averages +/- SEM of an experiment in triplicate. D-E) Cells 
were infected with an MOI of 1 PFU/cell with MHV. 0.4% DMSO, or 10, 20, or 40 µM 
EIPA were added times indicated post infection. Viral titer was measured at 12 h p.i. 
EIPA was added at 6 h p.i. (D) or at a concentration of 40 µM EIPA (E). Data are 
represented as mean +/- SEM of two replicates in duplicate. F-G) Cells were infected 
with MHV-FFL2 at an MOI of 1 PFU/cell. 0.4% DMSO or 40 µM EIPA was added at 8 
h p.i. Supernatant was collected at 10 h p.i. and titered. Cells were collected in luciferase 
lysis buffer and assessed for luminescence (F), or in DMEM and subject to three rounds 
of freeze-thaw before being titered (G). Data are represented as averages +/- SEM of two 
replicates in duplicate. Significance was assessed using one-way ANOVA with Dunnett’s 
post-hoc test. *p<0.05, **p<0.005, ***p<0.0005. 
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prior to infection caused a ≥ 80% decrease in MHV titer at 12 h p.i., while use of 
scramble siRNA or an siRNA against RhoA did not have a significant effect on titer 
(Figure 22A). Treatment with CdtA also caused a significant decrease in MHV titer at 10 
h p.i. (Figure 22B-C). EIPA was added to MHV-infected cell monolayers at different 
concentrations and times post-infection (Figure 22D-E).  EIPA treatment resulted in a ≥ 
75% decrease in virus titer when added anytime after 2 h p.i. To test the effect of EIPA 
on different stages in the virus life cycle, we infected cells with MHV expressing firefly 
luciferase as a fusion with the replicase protein nsp2 (Freeman et al., 2014) and measured 
FFL activity in the presence or absence of EIPA added at 8 h p.i. (Figure 22F). In 
replicate experiments, supernatant was collected at 10 h p.i. and cell-associated virus was 
collected by freezing and thawing infected cells three times. Titer was assessed in each 
sample by plaque assay (Figure 22G). Intracellular FFL-nsp2 expression from the viral 
genome was not altered by EIPA treatment. In addition, viral titer was significantly 
decreased in the supernatant of cells treated with EIPA, while intracellular virus titer was 
not affected by addition of EIPA. Together, these results indicate that EIPA does not 
effect intracellular virus replication, assembly, or maturation, but alters the overall peak 
of infectious virus in the supernatant, consistent with an effect on late stages of virus 
release or cell-cell spread.   
 
The presence of fusogenic spike protein at the plasma membrane is required to 
induce macropinocytosis 
Having determined that MHV-induced macropinocytosis requires active virus replication 
and occurs at a late stage in the virus life cycle, we investigated the role of the spike 
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protein in CoV-induced macropinocytosis, using MHV-A59 and recombinant MHV-2S. 
In MHV-A59, spike is cleaved by furin in the trans-Golgi network during virion 
maturation (de Haan et al., 2004), resulting in fusogenic spike on nascent virions and on 
the plasma membrane of infected cells. Interaction of the MHV-A59 spike with cellular 
receptor results in either virus-cell fusion and cell entry or cell-cell fusion and syncytia 
formation (de Haan et al., 2004). In contrast, the spike protein of another strain, MHV-2, 
is not cleaved by furin during exit of nascent virions, but rather is cleaved by cathepsins 
following endocytosis during entry (Qiu et al., 2006). Thus, released infectious MHV-2 
does not have fusogenic spike, and cells infected with MHV-2 do not express fusogenic 
spike on the cell surface or generate syncytia in culture.  
 
To test for the role of spike and spike fusogenic activity in MHV-induced 
macropinocytosis, we mock-infected or infected cells with MHV-A59 or with 
recombinant MHV-A59 encoding MHV-2 spike (MHV-2S) (Navas et al., 2001) and 
tested nanoparticle internalization (Figure 23). MHV-2S-infected cells internalized 
significantly fewer nanoparticles than MHV-A59-infected cells (Figure 24A). To test the 
specific requirement for spike cleavage, we infected cells with an MHV-A59 mutant C12 
(MHV-C12) containing an amino acid mutation (H716D) that abolishes the furin 
cleavage site (Hingley et al., 1994). During infection with MHV-C12 there was no 
significant difference in nanoparticle internalization compared to mock-infected cells 
(Figure 24A). We next used a furin inhibitor, peptidyl chloromethylketone (dec-RVKR-
cmk) (de Haan et al., 2004) to block furin cleavage of the MHV-A59 spike (Figure 24B). 
Treatment with dec-RVKR-cmk decreased both nanoparticle uptake and syncytia  
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Figure 23. Panel of spike viruses 
A schematic representation of the viruses used in this work with changes in the spike 
protein. MHV-A59 is considered “WT” in this work. MHV-2 is a different strain of 
MHV. MHV-2S contains only the spike protein of MHV-2 in an isogenic MHV-A59 
background. MHV-C12 contains a one amino acid mutation in the furin cleavage 
sequence of MHV-A59, H716D. 
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Figure 24. Fusogenically active spike protein is required to induce macropinocytosis 
A) Cells were mock-infected or infected with MHV-A59, MHV-2S, or MHV-C12 at an 
MOI of 1 PFU/cell. Nanoparticles were added at 5 h p.i. for 3 h and cells were washed, 
fixed, stained, and imaged. B-D) DBT cells were mock-infected or infected with MHV-
A59 at an MOI of 1 PFU/cell in DMEM or DMEM with DMSO or dec-RVKR-cmk 
(dRc) at infection for 8 h. dec-RVKR-cmk was added to cells for 12 h and toxicity 
assessed with CellTiter Glo (B). Nanoparticles were added 3 h prior to fixation, cells 
washed, fixed, stained, and imaged.  % syncytial cells (C) and % cells with internalized 
nanoparticles (D) were measured. E) Cells were mock-infected or infected with MHV-
A59, MHV-2S at an MOI of 1 PFU/cell. At 5 h p.i., cells were treated with TPCK trypsin 
for 5 m, washed, then nanoparticles were added for 3 h. Cells were washed, fixed, 
stained, and imaged. Data are represented as mean +/- SEM from two replicates in 
duplicate. n≥30 cells per replicate. Significance was assessed using one-way ANOVA 
with Dunnett’s post-hoc test, ***p<0.0001, **p<0.01, *p<0.05. 
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formation in a concentration-dependent manner (Figure 24C-D). To test whether spike 
cleavage alone was sufficient to induce macropinocytosis, we treated cells infected with 
MHV-2S with TPCK-trypsin in order to generate fusogenic spike protein on the cell 
surface, and assessed nanoparticle uptake. Cells infected with MHV-2S and treated with 
trypsin recovered the capacity for nanoparticle internalization (Figure 24E). Together, 
these results demonstrate that expression of fusion-competent spike protein at the plasma 
membrane is necessary for MHV macropinocytosis induction. 
 
MHV-induced macropinocytosis is associated with, but independent from, syncytia 
formation 
The necessity for cleaved spike in macropinocytosis induction could be explained by 
either a requirement for spike mediated cell-cell fusion, or by a direct role for spike in 
macropinocytosis induction. To distinguish between these possibilities, we used two 
approaches: induction of syncytia by different methods and blockade of syncytia 
formation with anti-receptor antibodies. To test the cell-fusion hypothesis, cells were 
chemically treated with PEG-1500 or transfected with the G protein of Vesicular 
Stomatitis Virus (VSV) (Figure 25A) to induce cell-cell fusion, then incubated with 
nanoparticles. While MHV induces syncytia of  ≥ 30 nuclei, both PEG-1500 treatment 
and VSV-G expression resulted in small syncytia with fewer than 10 nuclei. Nanoparticle 
uptake was compared between syncytia with 10 nuclei or less from MHV-infected cells, 
PEG-1500 treated cells and VSV-G transfected cells. PEG-1500 treatment resulted in 
nanoparticle uptake greater than mock-infected cells but significantly less than during  
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Figure 25. MHV-induced macropinocytosis is associated with, but independent 
from, syncytia formation 
A) DBT cells were mock-infected or infected with MHV-A59 at an MOI of 1 PFU/cell 
for 8 h, treated with PEG for 1 m, washed and incubated for 3 h, or transfected with 
VSV-G for 24 h. Nanoparticles were added 3 h prior to fixation, cells washed, fixed, 
stained, and imaged. Syncytia with ≤10 nuclei were analyzed. Data are represented as 
mean +/- SEM from two replicates, each in duplicate, n≥30 cells per replicate. B-C) Cells 
were mock-infected or infected with MHV at an MOI of 1 PFU/cell. α-CEACAM 
blocking antibodies were added at 2 h p.i., nanoparticles were added at 5 h p.i., and at 8 h 
p.i., cells were washed, fixed, stained and imaged. Nuclei per syncytium (B) and % cells 
with internalized nanoparticles (C) were measured. Significance was assessed using one-
way ANOVA with Dunnett’s post-hoc test. ***p<0.0001, **p<0.01, *p<0.05. 
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MHV infection. Expression of VSV-G did not result in increased nanoparticle uptake 
compared mock-infected cells. We next blocked the interactions of MHV-A59 spike with 
its cellular receptor, carcinoembryonic antigen (CEACAM), by adding α-CEACAM 
blocking antibodies at 2 h p.i., and measured the effect on syncytia size and nanoparticle 
uptake (Figure 25B). The α-CEACAM antibodies resulted in a significant reduction in 
syncytia cell number and size, but did not significantly decrease nanoparticle uptake by 
infected cells (Figure 25C). Together these results demonstrate that cleaved spike protein 
at the cell surface, and not cell fusion alone, is required to initiate and to sustain 
macropinocytosis. 
 
Coronavirus-induced macropinocytosis is dependent on activation of epidermal 
growth factor receptor (EGFR) 
Signaling through EGFR is essential for induction of macropinocytosis in several systems 
(Haigler et al., 1979; Mercer et al., 2010; Sanchez et al., 2012). To test whether EGFR 
activation is required for CoV-induced macropinocytosis, we utilized gefitinib, which 
specifically inhibits EGFR autophosphorylation and prevents EGFR activation (Moasser 
et al., 2001). DBT cells were mock-infected or infected with MHV-A59, gefitinib was 
added after viral entry at 1.5 h p.i., and cells were analyzed for nanoparticle uptake and 
syncytia size ( Figure 26A-C). Addition of gefitinib to MHV-infected cells significantly 
decreased the percentage of syncytia with internalized nanoparticles (Figure 26B). We 
also observed that gefitinib significantly decreased the number of nuclei in a syncytium, 
with only half as many nuclei as in a DMSO-treated syncytium (Figure 26C). We then  
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Figure 26. CoVs induce macropinocytosis via EGFR 
A) Gefitinib was added to cells for 12 h and toxicity assessed with CellTiter Glo. B-C) 
DBT cells were mock-infected or infected with MHV-A59 at an MOI of 1 PFU/cell in 
DMEM or DMEM supplemented with DMSO or gefitinib at 1.5 h p.i. Cells were fixed at 
8 h p.i. Nanoparticles were added 3 h prior to fixation, cells washed, fixed, stained, and 
imaged. % cells with internalized nanoparticles (B) and # nuclei per syncytium (C) were 
measured. D-E) DBT cells were mock-infected or infected with MHV-A59 at an MOI of 
1 PFU/cell in DMEM or DMEM supplemented with DMSO or EIPA at 1.5 h p.i. Cells 
were fixed at 8 h p.i., stained, and imaged. % infected cells involved in syncytia D) and # 
nuclei per syncytium (E) were measured. Data are means +/- SD in triplicate, n≥30 fields 
per replicate. Statistical significance was assessed using one-way ANOVA with 
Dunnett’s post-hoc test. ***p<0.0001, **p<0.01, *p<0.05. 
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evaluated the effect of EIPA on syncytia size, and discovered that treatment with EIPA 
decreased both the percentage of infected cells involved in syncytia (Figure 26D) and the 
size of the syncytia (Figure 26E). These data suggest that CoVs are utilizing EGFR 
activation to induce macropinocytosis and to initiate cell-cell spread. 
 
Discussion 
In this study, we demonstrate that MHV infection induces macropinocytosis, as defined 
by characteristic membrane ruffling, internalization of large pleomorphic vesicles, 
increased fluid phase uptake, dependence on Rac1, Cdc42, and Pak1, and sensitivity to 
EIPA. MHV-induced macropinocytosis requires cell-surface expression of cleaved, 
fusogenic spike and spike-mediated induction of macropinocytosis is dependent on direct 
or indirect interactions of spike with EGFR. We have summarized these data in the model 
shown in Figure 27.   
CoVs have been shown previously to modify cytoplasmic membranes to form viral 
replication complexes (Angelini et al., 2013). Here, we report that CoVs also have the 
capacity to modify the plasma membrane through the activation of the macropinocytosis 
pathway. Prior to this study the only role demonstrated for virus-induced 
macropinocytosis has been in virus entry. MHV-associated macropinocytosis, in contrast, 
is initiated relatively late during infection and is continuous once activated. MHV-2S 
does not stimulate cell-cell fusion or macropinocytosis in infected cells, but still causes 
disease in vivo, suggesting that macropinocytosis may not be required for fitness or 
pathogenesis of all strains of MHV or for all coronaviruses. The disease phenotypes for  
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Figure 27. Model of macropinocytosis during CoV infection 
 
MHV-2S enters the cell via endocytosis after the spike protein interacts with the 
CEACAM receptor. Spike is cleaved to its fusogenic form by cathepsins after entry via 
endocytosis and the virus fuses with the endosomal membrane to release the genome to 
the cytoplasm. Replication occurs and virions are assembled in the ERGIC, then 
packaged and released via exocytosis. Spike protein that reaches the surface of the cell is 
uncleaved (black ball and stick) and cannot mediate syncytia formation with neighboring 
cells. MHV-A59 enters the cell via fusion at the cell membrane after spike interacts with 
the CEACAM receptor. The genome immediately enters the cytoplasm and replication 
occurs. Packaging of nascent virions occurs in the ERGIC, and free spike proteins and 
spike incorporated into virions is cleaved by furin in the trans Golgi. Virions are 
packaged and released via exocytosis. Spike protein that reaches the cell surface is 
cleaved and fusogenically active (red ball and stick), and can mediate fusion events with 
neighboring cells.  This cleaved, activated spike protein can also mediate interactions, 
potentially through EGFR (purple ball and stick), that induce the macropinocytosis 
pathway within the cell, which relies on Rac1, Cdc42, and Pak1. Actin modifications at 
the cell surface then cause membrane ruffling and macropinosome internalization, in 
addition to filopodia that can facilitate spike-receptor interactions with neighboring cells. 
The location of spike cleavage is denoted by the red-striped regions.  
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MHV-A59 and MHV-2S differ, as infection with MHV-A59, but not MHV-2S, causes 
spinal cord demyelination (Das Sarma et al., 2000), suggesting that macropinocytosis  
driven cell-cell spread could be a tissue-specific strategy. The conservation of 
macropinocytosis during MHV and SARS-CoV infection, however, suggests that  
macropinocytosis induction could be an important determinant of pathogenesis for 
viruses capable of maintaining cleaved spike protein on the surface of infected cells.  
 
Our results demonstrate two consistent and dramatic phenotypes associated with MHV-
induced macropinocytosis: ruffling with vesicle internalization, and filopodia associated 
with cell fusion and recruitment into syncytia. The fact that inhibition of MHV-induced 
macropinocytosis impairs overall virus titer while not affecting entry or intracellular 
infectious virus, suggests the possibility of multiple functions that favor overall virus 
fitness: specifically recruitment of membranes and nutrients into infected cells and 
syncytia, enhancement of virus release, or virus cell-cell spread. MHV-A59 acquires its 
viral envelope by budding through the ERGIC, and is released from the cell without lysis 
via the exocytic pathway. No previous role for a traditionally endocytic pathway such as 
macropinocytosis has been reported to be used during viral release (Tooze et al., 1984; 
Tooze et al., 1987). The observed increase in formation of long filopodia from infected 
cells that contact and recruit uninfected cells into syncytia suggests a role for 
macropinocytosis as a mechanism by which CoVs potentiate cell communication over 
significant distances. Filopodia could act as mediators of CoV cell-cell fusion by 
concentrating spike protein and virus at the filopodia tip. Actin modifications have been 
previously implicated in cell-cell spread for other viruses. Vaccinia virus utilizes actin 
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tails to infect distant cells at a rate faster than infecting adjacent cells (Cudmore et al., 
1995; Doceul et al., 2010). HIV and HTLV use filopodia to create virological synapses to 
transfer infectious material from one cell to another (Igakura et al., 2003; McDonald et 
al., 2003). Macropinocytosis can occur in polarized cells (Mettlen et al., 2006), and could 
represent a novel mechanism of virus cell-cell spread over tight junctions within airway 
epithelium. Viral spread in this manner has several advantages over viral spread via 
exocytosis, specifically immune evasion, concentration of reagents, speed, and the 
capacity to circumvent physical barriers. Increasing the extent and duration of plasma 
membrane extensions could increase opportunities for interactions with adjacent or 
distant cells.   
 
Our results also show that expression of cleaved, fusogenic spike on the cell surface is 
necessary to induce macropinocytosis, whether by furin-mediated cleavage in the cell or 
by exogenous cleavage by trypsin on the cell surface. Induction of macropinocytosis also 
requires EGFR activation and signaling through the known macropinocytosis cellular 
pathway. Based on our results, we propose a model in which fusogenic spike protein on 
the plasma membrane results in EGFR activation, leading to a signaling cascade that 
manifests as increased membrane ruffling and filopodia formation to facilitate cell-cell 
fusion and virus spread.  Spike-EGFR interactions could occur at several cellular 
locations and be either direct or indirect. Spike protein localized at the plasma membrane 
could directly interact with neighboring EGFR. EGFR is also a highly trafficked receptor, 
which translocates to the mitochondria after activation (Demory et al., 2009), then 
promptly back to the plasma membrane, providing opportunities for interactions between 
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spike and EGFR within the cell. Proteins from other viruses have been previously shown 
to activate tyrosine kinase receptors in a ligand-independent fashion through 
transmembrane domain interactions, such as E5 of bovine papillomaviruses (DiMaio and 
Petti, 2013), or through the production of a cellular ligand, as in human papillomavirus 
16 (DiMaio and Petti, 2013).  
 
Our results raise many important questions for future studies. What is the relationship of 
GTPase and EGFR activation to specific stages in the viral life cycle? Does the virus 
receptor play a role in facilitating activation of EGFR and induction of macropinocytosis? 
How does the capacity to induce macropinocytosis favor fitness of MHV-A59? The 
results of our studies define novel roles for coronavirus spike protein and for 
macropinocytosis during coronavirus infection and raise the possibility that other RNA 
viruses may usurp macropinocytosis machinery for purposes other than virus entry.   
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Chapter IV: MERS-CoV ANTIBODIES 
Introduction 
In June 2012, MERS-CoV was isolated from a man with acute pneumonia and renal 
failure in Saudi Arabia (Zaki et al., 2012). The number of cases has increased to 827 with 
287 deaths by July 2014, with a majority of the case burden in the Arabian Peninsula.  
Evidence of MERS-CoV has been detected in Nycteris, Pipistrellus, and Taphozous bats 
(Annan et al., 2013) (Memish et al., 2013) as well as in dromedary camels. Person-person 
transmission has also been confirmed, though at this time it is less communicable than 
SARS-CoV (Reusken et al., 2013) (Meyer et al., 2014). Serological evidence suggests 
that MERS-CoV has been circulating in camels since at least 1992 (Alagaili et al., 2014). 
Presently, vaccines and specific antiviral pharmaceuticals are unavailable, so 
understanding the molecular mechanisms is incredibly important. 
 
All positive sense RNA viruses replicate on modified host cytoplasmic membranes. All 
Beta-CoVs investigated form two types of ER membrane modifications: double 
membrane vesicles and convoluted membranes (Knoops et al., 2008). Replication 
complexes are formed on these membranous structures. Coronaviruses contain large 
RNA genomes that range form 26-32kb and two-thirds of the genome encodes the 
replicase gene (Orf1a/b), which is translated into a large polyprotein that is cleaved into 
up to 16 nonstructural proteins (nsps 1-16) that are associated with viral replication 
(Perlman and Netland, 2009). The remainder of the genome encodes the structural 
proteins, spike, membrane, nucleocapsid, and envelope, as well as accessory proteins. All 
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replicase proteins investigated colocalize at the replication complexes, which are 
associated with the membrane modifications (Bost et al., 2000; Brockway et al., 2003; 
Gosert et al., 2002; Knoops et al., 2008; Snijder et al., 2006; van der Meer et al., 1999). 
Replication complexes appear to exclude most cellular marker but partially colocalize 
with ER proteins, PDI and sec61α (Knoops et al., 2010). The structural proteins localize 
to the ER-Golgi intermediate complex (ERGIC), which is the site of viral assembly (Sims 
et al., 2000).  
 
A great deal of progress has been made while studying this new pathogen since its 
emergence, but its intracellular replication strategies have not been investigated. It is 
unknown if nsps accumulate to form replication complexes, as in other coronaviruses, or 
if these complexes are morphologically and temporally similar to other coronaviruses. 
This chapter describes a collaborative study by our lab contributing to new knowledge of 
the newly emergent pathogen, MERS-CoV. Our lab has developed antibodies that 
specifically recognize MERS-CoV replication proteins. Clint Smith and Xiaotao Lu were 
responsible for protein design, purification, and initial testing of epitope recognition via 
dot blot, and I describe these portions of the project only briefly. I was responsible for 
clearing the antibodies on cells and initial testing of their function for 
immunofluorescence studies, including specificity testing, time course evaluation, and 
colocalization with other viral antibodies. Also included is some work done in 
collaboration with Barney Graham’s lab at the NIH testing antibodies directed against the 
MERS-CoV spike protein. Dia Beachboard completed the studies describing localization 
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of MERS-CoV antibodies with cellular markers. Clint Smith and Michelle Becker 
completed BSL3 work. 
This work demonstrates that these antibodies are specific and robust. It also shows that 
viral proteins are expressed long before cellular cytopathic effects are present. Viral 
proteins partially colocalize with PDI, the ER marker and colocalize with other replicase 
proteins. Spike protein colocalized with actin and WGA, a marker of the Golgi complex 
and did not colocalize with the replicase proteins. Because this pathogen is newly 
emerging, has many unknowns, and is very deadly, it is important to better understand its 
replication strategies such that they might be effectively targeted for therapeutic 
intervention.  
 
Purified antibodies specifically recognize MERS-infected cells 
Regions of MERS-CoV corresponding to replicase proteins nsp1, nsp8, nsp9, and nsp10 
were cloned into a SUMO expression vector, expressed in E. coli and purified (Figure 
28). Nsp5 protein was a gift from Andrew Messecar’s lab at Purdue University. Each 
purified protein was sent to Cocalico Inc., injected into rabbits or guinea pigs, and several 
bleeds were collected and tested for protein recognition via dot blot (data not shown). 
Antibodies were then cleared on DBT cells to eliminate non-specific binding. 
 
To test whether purified antibodies specifically recognized epitopes in MERS-CoV-
infected cells via immunofluorescence assays, WHO-Vero cells on glass coverslips were 
infected with MERS-CoV at an MOI of 1 PFU/cell for 24 hours, fixed in MeOH, 
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immunostained utilizing the new MERS-CoV antibodies, and examined by wide field 
microscopy (Figure 29). To control for specific expression, the preimmune serum of each  
 
 
 
Figure 28. Design of antibodies specific for MERS-CoV nsps 
Schematic of MERS-CoV genome is shown. The first 2/3 of the genome encodes the 
replicase gene that is translated to a polyprotein that is cleaved into 16 nsps (nsp 1-16). 
The last 1/3 encodes structural and accessory proteins. Full-length proteins were cloned 
into pSUMO vectors for protein expression of nsp1, 8, 9, and 10 (grey boxes). MERS-
CoV nsp5 was a gift from Andrew Messecar’s lab (Purdue University). Antibodies 
against the spike protein (striped box) were a gift from Barney Graham’s lab (NIH).  
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Figure 29. Antibodies directed against MERS-CoV nsps are specific for MERS-CoV 
infected cells 
WHO-Vero cells were mock-infected or infected with MERS-CoV at an MOI of 1 
PFU/cell. At 24 h p.i., cells were fixed in MeOH, stained with antibodies or pre-immune 
serum as indicated (α-nsp1, α-nsp5, α-nsp8, α-nsp9, α-nsp10) and secondary antibodies 
labeled with Alexa 546 and imaged by wide field microscopy. Nuclei are stained by 
DAPI. All images are at the same magnification. 
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antibody was also applied to infected cells, and the antibodies were tested against mock-
infected WHO-Veros. We also confirmed specific expression by testing our primary 
antibodies alone and our secondary antibodies alone (data not shown), and as expected, 
no fluorescence was detected. 
 
WHO-Vero cells infected with MERS-CoV and stained with antibodies directed toward 
nsp1, nsp5, nsp8, nsp9, and nsp10 demonstrated a punctate cytoplasmic pattern of 
localization that often formed a semicircular ring near the nucleus (Figure 29). Each of 
the antibodies, except for the antibody directed to nsp10, demonstrated very low 
background signal in contrast to the bright signal visualized in infected cells. None of the 
antibodies had signal present in the preimmune serum-stained samples. I used wide field 
microscopy for these experiments such that the background in the entire field could be 
discerned, instead of only the background within a z-slice. I used confocal imaging for all 
other images in this chapter. Because of the high background of the nsp 10 antibody, I did 
not evaluate it in additional studies. 
 
MERS-CoV replication proteins are evident as early as 6 hours post infection 
To test how early MERS-CoV replicase proteins could be recognized and visualized in 
infected cells, samples were prepared as before, but fixed at 6, 12, and 24 hours post 
infection (Figure 30). Specific signal was not expected at earlier times post infection, as 
MERS-CoV creates a very subtle CPE in our hands 1-2 days post infection. Surprisingly, 
robust signal for each antibody tested was visualized as early as 6 h p.i., although there  
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Figure 30. MERS-CoV proteins can be visualized as early as 6 h p.i. 
WHO-Vero cells were infected with MERS-CoV at an MOI of 1 PFU/cell. At 6, 12, or 
24 h p.i., cells were fixed in MeOH, stained with antibodies as indicated (α-nsp1, α-nsp5, 
α-nsp8, α-nsp9) and secondary antibodies labeled with Alexa 546. Cells were imaged by 
confocal microscopy. All images are at the same magnification. 
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were fewer cells with fluorescent signal in these samples than there were in the 12 h or 24 
h samples. 
 
MERS-CoV replication proteins colocalize with Golgi and ER markers 
In order to determine whether MERS-CoV replicase proteins colocalize with ER, Golgi, 
mitochondria or actin, co-immunostaining was performed (Figure 31). First, in order to 
determine whether MERS-CoV replicase proteins colocalize with ER markers, MERS-
CoV infected cells on glass coverslips were co-stained for each nsp and PDI. Both nsp8 
and nsp9 demonstrated partial colocalization with PDI, similar to previous studies with 
SARS-CoV nsp3 (Knoops et al., 2010). Other studies have demonstrated that some nsps 
relocalize to the site of viral assembly, the ERGIC, at late times post-infection (Bost et 
al., 2001). In order to test whether MERS-CoV nsps localize to the Golgi at 24 h p.i., we 
tested co-localization of each nsp with WGA (WGA N-acetyl-D-glucosamine and sialic 
acid residues). Foci from all nsps tested were distinct from the Golgi, suggesting that, at 
least at this time post-infection, replicase proteins do not relocalize to the Golgi, which 
may be important for future studies of viral assembly. 
 
Next, in order to determine whether other organelle markers were excluded from 
replication complexes, we analyzed colocalization of the nsps with mitochondria using 
the mitochondrial protein pyruvate dehydrogenase (PDH). Nsp1, nsp5, and nsp9 do not 
colocalize with PDH. There was partial colocalization of nsp8 and PDH, but it was only 
at the periphery of distinct foci, suggesting that the two compartments may be in close 
proximity. Current electron microscopy studies in our lab have demonstrated that  
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Figure 31. MERS-CoV replicase proteins and cellular markers 
WHO-Vero cells were infected with MERS-CoV at an MOI of 1 PFU/cell. At 24 h p.i., 
cells were fixed in MeOH, stained with antibodies as indicated. MERS-CoV replicase 
proteins are labeled with green and cellular markers are labeled in red. Confocal images. 
WGA-Golgi, PDH-mitochondria, Phalloidin-F-actin, PDI-ER. Yellow pixels correspond 
to colocalization of green and red. All images are at the same magnification. 
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mitochondria are often incredibly near, but distinct from double membrane vesicles (data 
not shown). Additionally, we tested colocalization with the actin cytoskeleton. For this, 
we labeled F-actin with phalloidin. As expected, none of the nsps evaluated colocalized 
with the actin cytoskeleton. Collectively, these data suggest that MERS-CoV forms 
replication complexes that are similar to other beta-CoVs, both in punctate expression in 
the perinuclear region of the cell and in patterns of localization with cellular markers.  
 
MERS-CoV antibodies directed against the spike protein are specific and robust 
In addition to the antibodies directed against the replicase proteins, I also have been 
working in collaboration with Barney Graham’s lab at the NIH to evaluate antibodies 
directed against the MERS-CoV spike protein. To test whether these antibodies 
specifically recognized epitopes in MERS-CoV-infected cells during 
immunofluorescence assays, WHO-Vero cells on glass coverslips were infected with 
MERS-CoV at an MOI of 1 PFU/cell for 24 hours, fixed in MeOH, immunostained 
utilizing the MERS-CoV antibodies directed against spike protein, and examined by wide 
field microscopy (Figure 32). Each of the Spike antibodies, D12, F11, G2, and G4, 
demonstrated specificity for MERS-CoV infected cells. 
 
MERS-CoV antibodies directed against the spike protein coloclalize with actin and 
Golgi markers. 
To investigate the cellular localization of the spike protein, WHO-Vero cells on glass 
coverslips were infected with MERS-CoV at an MOI of 1 PFU/cell for 24 hours, fixed in 
10% formalin, permeabilized with 1% Triton X-100, co-immunostained utilizing the  
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Figure 32. Different antibodies designed against MERS-CoV Spike protein 
specifically recognize infected cells 
WHO-Vero cells were infected with MERS-CoV at an MOI of 1 PFU/cell. At 24 h p.i. 
cells were fixed in MeOH, stained with antibodies as indicated and secondary antibodies 
labeled with Alexa 546. Cells were imaged by wide field microscopy. Nuclei are stained 
with DAPI. All images are at the same magnification. 
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MERS-CoV antibodies directed against spike protein (G2) and antibodies directed either 
against the WGA, to represent the Golgi, or with phalloidin toxin, to stain the actin 
cytoskeleton (Figure 33). Coverslips were examined by confocal microscopy. Spike 
staining of infected cells was discovered to coloclalize both with actin at the cell surface 
and with WGA, the Golgi marker. This staining pattern is consistent with the spike 
protein of other coronaviruses, and corresponds to mature spike in the Golgi trafficking 
out to the cell surface. 
 	  
Replicase proteins localize to replication complexes, while spike protein exists in the 
Golgi and at the surface of the cell 
In order to evaluate colocalization of MERS-CoV nsps and spike, WHO-Vero cells on 
glass coverslips were infected with MERS-CoV at an MOI of 1 PFU/cell for 24 hours, 
fixed in MeOH, and co-stained with each of our nsp antibodies raised in rabbits with the 
nsp8 antibody raised in guinea pigs and the spike antibodies raised in mice (Figure 34). 
During co-staining experiments, the all nsps colocalize with nsp8 at perinuclear foci, and 
spike has a distinct pattern of localization separate from the nsps. Visually, there 
appeared to be differences in the number of foci or intensity of some proteins. When 
testing nsp5 and nsp8, all of nsp8 colocalizes with nsp5 but there are some nsp5 foci that 
do not colocalize with nsp8. This suggests that, while all of the nsps tested localize to 
sites of viral replication, nsps may be present at the replication complexes in different 
quantities or arrive there with temporal differences. 
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Figure 33. MERS-CoV spike protein localizes to the interior and exterior of the cell 
WHO-Vero cells were infected with MERS-CoV at an MOI of 1 PFU/cell. At 24 h p.i., 
cells were fixed with 10% formalin, permeabilized where indicated, and stained with 
antibodies (α-spike G2) and secondary antibodies labeled with Alexa 488. Cells were 
costained with WGA directly conjugated to Alexa 555 or phalloidin conjugated to Alexa 
546. Cells were imaged by confocal microscopy. All images are at the same 
magnification. 
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Figure 34. MERS-CoV nsps colocalize to replication complexes, while spike localizes 
to the interior and exterior of the cell 
WHO-Vero cells were infected with MERS-CoV at an MOI of 1 PFU/cell. At 24 h p.i., 
cells were fixed in MeOH, stained with antibodies as indicated and secondary antibodies 
labeled with Alexa 546 (rabbit nsps), 488 (guinea pig nsp8), or 633 (mouse spike). Cells 
were imaged by confocal microscopy. Yellow pixels correspond to colocalization of 
green and red. All images are at the same magnification. 
 
 
	  86	  
 
Discussion 
MERS-CoV is an important infectious agent with severe consequences for human health. 
In this work, we have developed antibodies specific for several MERS-CoV nonstructural 
proteins. We have tested these proteins to determine that they are highly specific and 
robust for use in immunofluorescence studies. We have determined that MERS-CoV nsps 
localize to punctate perinuclear foci, as is seen for other coronaviruses. Specific signal is 
visualized for each antibody as early as 6 h p.i. Each nsp tested colocalizes with nsp8, 
another of the replicase proteins. Antibodies directed against the nonstructural proteins do 
not coloclalize with markers against actin, the Golgi network, or mitochondria, but do 
partially coloclalize with ER markers. Antibodies directed against the spike protein 
coloclalize with actin and with the Golgi, but not with replicase proteins. 
 
Interestingly, the patterns of localization seen in immunostaining for MERS-CoV 
nonstructural proteins has similarities and differences from other previously studied 
coronaviruses. While each nsp demonstrated a pattern of punctate, perinuclear 
localization, much like other CoVs studied, the signal for MERS-CoV seemed to often 
form a distinct semi-circular ring around the nucleus with less thickness than seen in the 
other CoVs. The foci also seemed to be fewer in number than in other viruses studied, 
although each was very bright in its intensity. This could suggest that there is a tight 
special regulation associated with this virus. Patterns of colocalization between nsps were 
as expected, as were patterns of colocalization between evaluated nsps and cellular 
markers, with nsps demonstrating some degree of colocalization with ER markers, but 
not with any of the other cellular markers tested.  Antibodies against the spike protein 
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demonstrated expected colocalization as well, with overlap in signal with both actin and 
markers for the Golgi. The timing of protein expression in MERS-CoV-infected cells was 
also surprising. In our hands, MERS-CoV does not have a robust expression of CPE, and 
even when it is visualized, it is multiple days post-infection. Protein production was 
visualized as early as 6 h p.i., which is an indicator that cells are actively infected at this 
point. 
 
Interestingly, while we had great success with the strategy of utilizing the entire nsp as an 
antigen for most of the nonstructural proteins tested, this was less effective for nsp10. 
This brings to light a potential immunogenicity difference between different proteins or 
regions of the genome. Other strategies, such as truncations of the protein or peptide 
antigens, may be employed with greater success for nsp10.  
 
Antibodies generated against MERS-CoV nonstructural proteins are specific and robust. 
They will be a valuable resource for future studies of MERS-CoV replication. These 
reagents and additional nsp-specific antibodies being developed in the laboratory will be 
critical in future studies of protein processing, nonstructural protein interactions, and 
protein localization.  
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Chapter V: MATERIALS AND METHODS  
Viruses, cells, plasmids, and antibodies 
Recombinant murine hepatitis virus strain A59 (WT), GenBank sequence AY910861 
(Denison et al., 2004; Sperry et al., 2005), was used as WT for MHV experiments. Work 
with SARS-CoV was completed using the reverse genetics infectious clone based on the 
Urbani strain (Yount et al., 2003). Work with MERS-CoV was completed with the 
recombinant clone (Scobey et al., 2013). Viral studies with SARS-CoV and MERS-CoV 
were preformed in a Select Agent certified BSL-3 laboratory using protocols reviewed 
and approved by the Institutional Biosafety Committee of Vanderbilt University and the 
Centers for Disease Control for the safe study and maintenance of SARS-CoV. MHV-
Δnsp2 virus with in-frame deletion of nsp2, and MHV-ΔCS2 with deletion of the nsp2-3 
cleavage site P1 Glu, were previously described (Graham et al., 2005). MHV-2S and 
MHV-C12 were kind gifts from Susan Weiss (U Penn) and have been previously 
described (Gombold et al., 1993; Navas et al., 2001). Delayed brain tumor (DBT) cells 
(Hirano et al., 1976), WHO Vero cells (Scobey et al., 2013) and baby hamster kidney 
cells expressing the MHV receptor (BHK-MHVR) (Chen et al., 1997; Lin et al., 1996) 
were grown in Dulbecco’s Modified Eagle Medium (DMEM) with 10% fetal bovine 
serum (FBS), 1% 1M HEPES, 100 units/ml of penicillin, 100 µg/ml streptomycin, and 
0.23 µl/mL amphotericin B. Medium for BHK-MHVR cells was supplemented with 
G418 (0.8 mg/ml) for selection of cells expressing the receptor. DBT cells expressing the 
SARS-CoV receptor (DBT-hACE2) (Sheahan et al., 2008) were cultured as previously 
described. VSV-G plasmid was a kind gift from Michael Whitt (UTHSC) (Robison and 
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Whitt, 2000). The polyclonal antibodies used in biochemical and imaging experiments 
have been previously described. All polyclonal antibodies were raised in rabbits unless 
indicated. For MHV, these include antibodies specific for nsp1 (VU221) (Brockway et 
al., 2004), nsp2 (VU154) (Sims et al., 2000), nsp3 (VU164) (Graham et al., 2005), and 
nsp8 (VU123) (Bostwick et al., 2000).  Mouse monoclonal α-firefly luciferase (FFL), 
clone LUC-1, was purchased from Sigma-Aldrich. Mouse monoclonal antibody specific 
for full-length GFP was purchased from SantaCruz Biotechnology. Mouse monoclonal 
antibody against the viral Membrane protein (M) was generously provided by J. Fleming 
(University of Wisconsin, Madison). Alexa Fluor 488 phalloidin (Molecular Probes) was 
used to stain for F-actin. Rabbit polyclonal α-CDC42-c terminal ab155940, rabbit 
polyclonal α-RhoA ab86297, mouse monoclonal α-GAPDH [6C5] ab8245, mouse 
monoclonal α-Rac1 [0.T.127] ab33186, and rabbit monoclonal α-Pak1 (phosopho S144) 
[EP656Y] ab40795 were purchased from abcam. Rabbit polyclonal antiserum specific for 
CEACAM was a kind gift from Tom Gallagher (Loyola University Chicago) (Thorp and 
Gallagher, 2004). Mouse monoclonal antibodies against protein disulfide isomerase (PDI; 
BD Transduction Laboratories) and pyruvate dehydrogenase (PDH, Invitrogen) were 
used. WGA directly conjugated to Alexa 555 (Invitrogen) was used to stain the Golgi 
complex and phalloidin directly conjugated to Alexa 546 (Invitrogen) was used as a 
probe for F-actin. C. difficile toxin A was a kind gift from Borden Lacy (Vanderbilt 
University) (Chumbler et al., 2012). The spike antibodies were a gift from Barney 
Graham (NIH).  
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Generation of antibodies directed against MERS-CoV replicase proteins 
For generation of antibodies directed against the MERS-CoV replicase proteins, the 
MERS-CoV genome was used as a template for reverse-transcription-PCR amplification 
of full-length proteins, cloned into pSUMO protein expression vectors, and purified. 
Protein generated for antibody production were the following: nsp1, nsp 8, nsp9 and 
nsp10. Additionally, nsp5 protein was received from Andrew Mesecar. New Zealand 
White rabbits were immunized with the purified proteins for antibody production 
(Cocalico, Inc.). After initial inoculation, rabbits were boosted at day 14 and day 21, and 
test bleeds were performed. Rabbits were boosted again at day 49, and sera from 
production bleeds on day 56 were used in the experiments in this report. For all studies, 
preimmune sera from the same rabbits were matched with immune sera. 
 
Construction of mutant MHV cDNA plasmids 
Insertions of reporter genes in place of the nsp2 coding sequences of MHV were 
engineered using PCR with primers as shown in Table 1. For ABCDEF primer sets, 
primers A and B generated an A/B PCR product, primers C and D generated a C/D PCR 
product, and primers E and F generated an E/F PCR product. AB, CD, and EF PCR 
amplicons were ligated into an ABCDEF product using the class IIs restriction enzyme 
method, and ligation products were cloned into the appropriate fragment A vector using 
unique sites: 5’-Sac II and 3’-Nde I. Successful insertions of reporter gene sequences 
were confirmed by restriction digestion and sequencing. The infectious cDNA fragment 
A construct (pCR-XL-Topo-A), which consists of genome nts 1 to 4882, was used as 
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template DNA (Yount et al., 2002). Reporter genes were cloned from pEGFP-C1 (GFP, 
Clontech) and pGEM-Luc (firefly luciferase, Promega).  
 
Generation of MHV reporter viruses 
Viruses containing PCR-generated insertions within the viral coding sequence were 
produced using the infectious cDNA assembly strategies for MHV as previously 
described, with modifications (Denison et al., 2004; Sperry et al., 2005; Yount et al., 
2003; Yount et al., 2002). Plasmids containing the seven cDNA cassettes of the MHV 
genome were digested using Mlu I, BsmB I, and Sfi I for fragment A, Bgl I and BsmB I 
for fragments B and C, BsmB I and Nci I for fragments D and E, BsmB I for fragment F, 
and BsmB I and Sfi I for fragment G. Digested, gel-purified fragments were ligated 
together in a total reaction volume of ~100 µl overnight at 16oC. Following chloroform 
extraction and isopropanol precipitation of ligated DNA, capped, polyadenylated full-
length RNA transcripts of MHV infectious cDNA were generated in vitro using the 
mMessage mMachine T7 Transcription Kit (Ambion) following the manufacturer’s 
protocol with modifications. Twenty-microliter reactions were supplemented with 3 µL 
of 30 mM GTP, and transcription was performed at 40.5oC for 25 minutes, 37.5oC for 50 
minutes, and 40.5oC for 25 minutes. In parallel, capped, polyadenylated RNA transcripts 
encoding the corresponding nucleocapsid proteins (N) were generated in vitro using N 
cDNA generated from PCR (Yount et al., 2003; Yount et al., 2002). N transcripts and 
mutant viral transcripts were then mixed and electroporated into BHK-MHVR cells. Cells 
were grown to sub-confluence, trypsinized, then washed twice with PBS and resuspended 
in PBS at a concentration of 107 cells/ml. Six hundred µl of cells were then added to 
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RNA transcripts in a 4-mm gap electroporation cuvette (BTX), and three electrical pulses 
of 850 V at 25 µF were delivered with a Bio-Rad Gene Pulser Xcell electroporator. 
Transfected cells were then seeded onto a layer of 106 uninfected DBT cells in a 75-cm2 
flask and incubated at 37oC for 30-90 h. Virus viability was determined by syncytia 
formation. T25s of cells were infected with supernatant, then the RNA was harvested 
using TRIzol (Invitrogen) according to the manufacturer’s instructions, and retention of 
reporters was verified by RT-PCR and sequencing. 
 
Microscopy 
DBT cells grown to 60% confluency on 12-mm glass coverslips were infected with 
designated viruses. At 10 h p.i., medium was aspirated from cells, and cells were fixed 
and permeabilized in methanol at -20oC overnight. WHO-Vero cells grown to 60% 
confluency on 12-mm glass coverslips were infected with MERS-CoV at an MOI of 1 
PFU/cell for the time designated. Vero cells grown to 60% confluency on 12-mm glass 
coverslips were infected with SARS-CoV at an MOI of 1 PFU/cell for the time 
designated. Viral studies with MERS-CoV or SARS-CoV were preformed in a BSL-3 
laboratory using protocols reviewed and approved by the Institutional Biosafety 
Committee of Vanderbilt University and the Centers for Disease Control for the safe 
study and maintenance of MERS-CoV and SARS-CoV. Cells were rehydrated in PBS for 
20 min and blocked in PBS containing 5% bovine serum albumin (BSA). Blocking 
solution was aspirated, and cells were washed with immunofluorescence (IF) assay wash 
solution (PBS containing 1% BSA and 0.05% Nonidet P-40) at room temperature. Cells 
were incubated in primary antibodies where indicated, 1:1000; or α-FFL (Sigma-
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Aldrich), 1:1000 for 45 m. Cells were washed in IF wash solution 3 times for 5 min per 
wash. Cells were incubated in secondary antibodies (Goat α-rabbit-AlexaFluors 488 
(1:1000) or 546 (1:1500), Invitrogen Molecular Probes) for 30 min. Cells were washed 3 
times for 5 min per wash, followed by a final wash in PBS, and then rinsed in distilled 
water. Coverslips were mounted with Aquapolymount (Polysciences) and visualized by 
confocal immunofluorescence microscopy on a Zeiss LSM 510 laser scanning confocal 
microscope at 488 and 543 nm with a 40X oil immersion lens. Images were processed 
and assembled using Nikon Elements, ImageJ, and Adobe Photoshop CS5 (12.0x64). All 
images were processed side-by-side with mock images. 
 
Protein immunoprecipitations 
For protein labeling and immunoprecipitation experiments, cells were infected with 
MHV and incubated at 37oC. At 2.5 h p.i., medium was aspirated and replaced with 
medium lacking methionine and cysteine and supplemented with actinomycin D (Sigma) 
at a final concentration of 20 µg/ml. At 3.5 h p.i., cells were labeled with [35S]-
Methionine/Cysteine ([35S]-Met/Cys) at a concentration of 0.08 mCi/ml. Radiolabeled 
cells were lysed in 1 ml no-SDS lysis buffer (1% NP-40, 0.5% sodium deoxycholate 
(DOC), 150 mM sodium chloride (NaCl), and 50 mM Tris pH 8.0) at 10-14 h p.i. 
Cellular debris and nuclei were pelleted by centrifugation at 14,000 × g for 3 min at RT, 
and the supernatant was transferred to a fresh tube. Fifty microliters of cell lysate was 
subsequently used per 400 µl of immunoprecipitation reaction buffer. Lysate was 
combined with protein A-sepharose beads and a 1:200 dilution of antibody in no SDS 
lysis buffer supplemented with 1% SDS. After incubation at 4°C for 18 h, beads were 
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pelleted and washed with low-salt lysis buffer (no-SDS lysis buffer with 150 mM NaCl) 
followed by high-salt lysis buffer (no-SDS lysis buffer with 1 M NaCl) and a final low-
salt wash. After rinsing, proteins were eluted by the addition of 2X LDS (lithium dodecyl 
sulfate) + 1X DDT buffer (NuPage, Invitrogen) to the pelleted beads, which were heated 
at 70oC for 10 minutes prior to electrophoresis of the supernatant on 4-12% Bis-Tris or 3-
8% Tris-Acetate gels (NuPage, Invitrogen). Gels were imaged by autoradiography. 
 
Viral replication assays 
For viral replication analysis, DBT cells were infected in triplicate with WT MHV or 
mutant viruses at the MOI indicated for each experiment. Following a 30-minute 
adsorption with rocking at RT, media was aspirated, and cells were washed 3 times with 
PBS and then incubated with pre-warmed media at 37oC. Aliquots of media were 
collected from 1 to 24 h p.i., and virus titers were determined by plaque assay on DBT 
cells in duplicate as described previously (Lavi et al., 1984). EIPA (Sigma) was applied 
during infection as indicated. 
 
Competition assay 
Confluent monolayers of DBT cells in T25 flasks were infected with WT MHV or MHV-
GFP2 alone or at a 1:1, 1:10, or 10:1 ratio of WT MHV to MHV-GFP2 at a total MOI of 
0.1 PFU/cell. Each flask was passaged 10 times as described for serial virus passage and 
1 mL supernatant was collected and stored at −80°C. DBT cells were seeded on glass 
coverslips and infected at an MOI of 1 PFU/cell with P1, P3, and P10 of each 
combination of viruses. At 8 h p.i., slides were fixed with cold MeOH. Coverslips were 
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immunostained with primary antibodies specific for nsp8 and secondary antibodies, goat 
α-rabbit AlexaFluor 546, as described above. Coverslips were mounted with 
Aquapolymount (Polysciences) and visualized by immunofluorescence microscopy on a 
Nikon Eclipse TE-2000S wide field fluorescent microscope. Cells were imaged using a 
40X oil-immersion lens through DIC, FITC, Cy3, and DAPI filters. Resulting images 
were merged and assembled using Nikon Elements, ImageJ, and Adobe Photoshop CS2. 
Infected and mock-infected cells were processed in parallel. Competition was assessed by 
counting the number of cells expressing GFP-nsp2 costained for nsp8 with Alexa 546 
versus the number of cells stained for nsp8 with Alexa 546 alone. 
 
Luciferase activity versus viral replication assay 
DBT cells in 6-well plates were infected with MHV-Δ2-FFL3 or MHV-FFL2 at an MOI 
of 1 PFU/cell and incubated at 37oC for 30 min. At 0.5 h p.i., media was aspirated to 
remove inoculum, cells were washed three times with PBS, and supplemented with pre-
warmed media. At time points through 24 h p.i., supernatant was harvested, or cells were 
lysed in Reporter Lysis Buffer (Promega) and subjected to one freeze-thaw cycle. 
Following freeze-thaw, lysates were vortexed and centrifuged briefly at top speed, and 
supernatants transferred to new tubes. To measure luciferase activity, 20 µL of lysate was 
added to each well of an opaque 96-well plate. Plates were loaded onto a Veritas 
luminometer and the automatic injector was used to add 100 µl of reconstituted 
Luciferase Assay Reagent (Promega) to each well as the samples were being read, 5 s per 
well, 0 s delay. Viral replication was determined from harvested supernatants by plaque 
assay as above. 
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Live-cell imaging of MHV infected cells 
DBT cells were seeded onto 35mm MatTek glass bottom culture dishes for 48 hours. 
Cells were then infected with MHV-Δ2-GFP3 at an MOI of 1 PFU/cell. In a separate 
experiment, cells were transfected with a GFP-expressing plasmid before being infected 
with MHV-A59 at an MOI of 1 PFU/cell. Plates were transferred to a live-cell incubator 
surrounding the objective stage of a Nikon Eclipse TE-2000S widefield fluorescent 
microscope. In the viral entry experiment, cells were infected with DiI labeled MHV-A59 
at an MOI of 25 PFU/cell and the infection was synchronized at 4° C for 30 minutes 
before imaging. Cells were imaged using a 40X oil-immersion lens through DIC and 
FITC short pass filters, with images captured at 30-second intervals. Resulting images 
were assembled into movies using Nikon Elements, ImageJ, Adobe Photoshop CS5 and 
Quicktime Pro. 
Determination of bulk fluid uptake and fixed ruffling 
DBT cells grown to 80% confluency on 12-mm glass coverslips were infected with 
MHV-A59 at an MOI of 1 PFU/cell. At designated times p.i., 100µg/ml 800nm 
fluorescent polystyrene nanoparticles (Corpuscular Inc.) were added to cells and 
incubated for 3 h at 37ºC. DBT-hACE2 cells were infected with SARS-CoV for 24 h at 
an MOI of 0.1 PFU/cell and 100µg/ml nanoparticles were added during the final 3 h prior 
to fixation. Cells were washed with media 3 times for 5 minutes. Drugs were added 
where indicated. Cells were fixed in 100% methanol or 10% formalin, then put at -20°C 
or 4°C, respectively, overnight. Cells were rehydrated in PBS for 10 min and blocked in 
PBS containing 5% bovine serum albumin (BSA). The coverslips were immunostained 
and imaged as described above in “Microscopy”. Scores for ruffling events were 
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calculated by encrypting the images and allowing three independent blinded reviewers to 
evaluate if a cell was positive or negative for ruffling, utilizing fixed criteria and a binary 
system. Cells were determined to have internalized nanoparticles based on a binary 
scoring system. Number of cells analyzed per sample as indicated. 
 
Fluorescent labeling of virions 
Viral stocks of MHV-A59 were grown on DBT cells and purified using a sucrose cushion 
with 5.5mL of 20% sucrose (20% sucrose, 0.1 M MgSO4, 50 mM HEPES, 150mM 
NaCl, pH 7.4, 0.2µM filtered) layered over 1.5 mL of 60% sucrose (20% sucrose, 0.1 M 
MgSO4, 50 mM HEPES, 150mM NaCl, pH 7.4, 0.2µM filtered) and spun at 27,000 RPM 
at 4° C for 90 min. Virions were then incubated with 5 uM 1,1'-Dioctadecyl-3,3,3',3'-
Tetramethylindocarbocyanine Perchlorate (DiI) (Life Technologies) for 1 h at room 
temperature and purified using a sucrose cushion with 1.5 mL 20% sucrose layered over 
1 mL 60% sucrose  and spun at 28,000 RPM at 4° C for 90 min to remove free dye. 
 
Toxicity assays 
Cellular toxicity for EIPA (Sigma), C. difficile toxin A (CdtA) (Lacy lab, Vanderbilt), 
peptidyl chloromethylketone (dec-RVKR-cmk) (Calbiochem), and Gefitinib (Selleck 
Chemicals) were tested at 12 h post treatment with DBT cells using Cell Titer Glo 
(Promega) protocol at following manufacturer’s instructions.  
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siRNA assays 
siRNA SMARTpools for murine Cdc42, Rac1, Pak1, RhoA, and scramble were obtained 
from ThermoScientific. DBT cells were reverse transfected per the protocol for 
Lipofectamine RNAiMAX (Life technologies). For siRNA and infection, cells were 
reverse transfected for 68 h, infected with MHV at an MOI of 1 for 8 h, and nanoparticle 
and fixation protocols were completed as described above. To test protein knockdown, 
cells were reverse transfected, incubated for 72 h, harvested with non-SDS lysis buffer, 
subjected to immunoblot analysis, and imaged with the Odyssey Imaging System (Licor). 
Band intensity was quantified and normalized to GAPDH using ImageJ. siRNA 
transfection efficiency was tested with transfection of AllStars Negative siRNA 
AlexaFluor 488 (Qiagen). 
 
UV-inactivation and heat-inactivation assays 
MHV was UV-inactivated by placing 1 mL of stock in an open 30 mm dish in a UV 
cross-linker for 45 minutes. MHV was heat-inactivated by placing 1 mL of stock at 70°C 
for 45 minutes. Inactivated virus was titered by plaque assay and determined to be 
inactivated when plaque formation was absent. DBT cells were mock-infected or infected 
with MHV-A59, UV-inactivated virus, or heat inactivated virus at an MOI of 1 or an 
equivalent volume of non-infectious virus for 8 h. 
 
Cell-associated assay 
DBT cells were infected with MHV-FFL2 at an MOI of 1 PFU per cell. At 8 h p.i., cells 
were washed 2x with PBS, then DMSO or EIPA was added. At 10 h p.i., supernatant was 
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collected and cell monolayers were harvested in DMEM and subject to 3 rounds of 
freeze-thaw. Each fraction was titered by plaque assay as previously described. Cells 
from a parallel experiment were collected in Luciferase Assay Buffer (Promega) and 
assessed for luminescence via the manufacturer’s protocol. 
 
Furin inhibition assay 
DBT cells grown to 80% confluency on 12-mm glass coverslips were mock-infected or 
infected with MHV-A59 at an MOI of 1 PFU per cell. Cells were untreated, treated with 
0.25% DMSO, or treated with increasing concentrations of peptidyl chloromethylketone 
(dec-RVKR-cmk) (Sigma) at the time of infection. Nanoparticle assays were completed, 
cells fixed and stained as described above, then imaged, and assessed for nanoparticle 
uptake and syncytia formation. 
 
Fusion assays 
DBT cells grown to 80% confluency on 12-mm glass coverslips were treated for 1 min 
with PEG-1500 (Sigma) and rinsed 3x with PBS before incubation with nanoparticles for 
3 h. Nanoparticle assays were completed, cells fixed and stained, imaged, and assessed 
for nanoparticle uptake and syncytia formation. Alternatively, cells were grown to ~60% 
confluency and transfected with VSV-G per the protocol for Lipofectamine 2000 (Life 
Technologies) for 24 h before nanoparticle incubation for 3 h. DBT cells grown to ~80% 
confluency on 12-mm glass coverslips were infected with MHV-A59 or MHV-2S at an 
MOI of 1 PFU per cell. At 5 h p.i., cells were treated with 2.5 µg/ml TPCK trypsin 
(Sigma) for 5 m, washed 1x with PBS, nanoparticles were added and incubated for 3 h, 
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washed, fixed, stained, and imaged. DBT cells grown to 80% confluency on glass 
coverslips were mock-infected or infected with MHV at an MOI of 1 PFU per cell. α-
CEACAM blocking antibodies were added at 2 h p.i., nanoparticles were added at 5 h p.i. 
for 3 h and cells were washed, fixed, stained and imaged. DAPI was used to stain nuclei. 
Number of nuclei per syncytium were measured, and the number of fields counted are as 
indicated. 
 
Antibody clearance 
WHO Vero cells were grown to 80% confluency in 6-well plates. Cells were rinsed of 
DMEM and 500 µL of antibody was applied to a well of cells and incubated with rocking 
at room temperature for 1 hour. Antibody was collected and centrifuged to remove 
cellular debris.  
 
Statistical analysis 
Statistical tests were applied as noted within the figure legends and were determined 
using GraphPad Prism (La Jolla, CA) software. Statistical significance is denoted as 
stated in the legends and was determined using a one-way analysis of variance (ANOVA) 
with Dunnett’s multiple-comparison test compared to uninfected or vehicle-treated 
samples. P values of <0.05 were considered to be statistically significant. 
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Table 1. Primers used for generation of reporter insertions 
 
Primer 
Name 
Sequencea Used to 
amplify 
Sense Comments 
MHV A 5’-
AACGGCACTTCCTGCGTGTCCAT
G 
MHV nsp1 + Common MHV left nsp1 
primer 
MHV B 5’-
CGTCTCCCTTAACACCGCGATAG
CCCTTAAGAAGAG 
MHV nsp1 - Common MHV right nsp1 
primer 
MHV-GFP 
C 
5’-
CGTCTCCTAAGATGGTGAGCAAG
GGCGAGGAGCTGT 
GFP +  
MHV-GFP 
D 
5’-
CGTCTCGTGCCCTTGTACAGCTC
GTCCATGCCGAGAGT 
GFP - MHV-Δ2-GFP3 
MHV-GFP 
D 
5’-
CGTCTCGTAACCTTGTACAGCTC
GTCCATGCCGAGAGT 
GFP - MHV-GFP2 
MHV-FFL 
C 
5’-
CGTCTCCTAAGATGGAAGACGCC
AAAAACATAAAGAAAG 
FFLb +  
MHV-FFL 
D 
5’-
CGTCTCGTGCCCAATTTGGACTTT
CCGCCCTTCTT 
FFL - MHV-Δ2-FFL3 
MHV-FFL 
D 
5’-
CGTCTCGTAACCAATTTGGACTTT
CCGCCCTTCTT 
FFL - MHV-FFL2 
MHV E 5’-
CGTCTCGTATCGCGGTGTTAAGA
AAGTCGAGTTTAAC 
MHV nsp3 + Common MHV left nsp3 
primer 
MHV F 5’-
ACTTGCACATATGAGACACAACG
TCCCCA 
MHV nsp3 - Common MHV right nsp3 
primer 
aUnderlining indicates residues added for cloning or mutagenesis purposes 
bFirefly luciferase 
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Chapter VI: SUMMARY AND FUTURE DIRECTIONS 
It is estimated that coronaviruses have been human pathogens for at least 500-800 years 
(Graham et al., 2013), though it wasn’t until the 1960s that the first human coronaviruses, 
HCoV-229E and -OC43, were described as agents of the common cold. Coronaviruses 
became increasingly publicized with the outbreaks of SARS-CoV in 2002-2003 and 
MERS-CoV ten years later in 2012. Both the continued circulation of a SARS-CoV-like 
bat CoV capable of utilizing the SARS-CoV receptor ACE2 (Ge et al., 2013) and the 
emergence of MERS-CoV suggests that emergence of CoVs causing severe and lethal 
human disease might be more common than realized. Thus, understanding viral and host 
factors essential for efficient replication will enable us to prevent and treat infections, as 
well as control potential future pandemics.  
 
The work in this dissertation specifically focuses on the unique capacity of coronaviruses, 
much like other positive-sense RNA viruses, to modify host cellular membranes during 
various stages of the viral lifecycle. This chapter will summarize the main findings of this 
dissertation in three parts: 1) the use of novel reporter viruses to visualize CoV 
replication in real-time, 2) the discovery that macropinocytosis occurs constitutively post-
entry during CoV infection and is likely important for viral spread, and 3) the use of 
newly developed antibodies that provide the first images of MERS-CoV replication 
complexes. Finally, this chapter will highlight interesting new questions and future 
directions generated as a result of these studies.  
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Visualizing CoV replication in real-time using novel reporter viruses 
Reporter protein sequences have been introduced into genomes of multiple coronaviruses 
to allow identification of infected cells or as surrogates for virus replication. However, 
these approaches have used either replicons or expression of reporter molecules in place 
of “accessory” proteins from 3’ open reading frames. Reporters expressed from 3’ ORFS 
are diffuse in the cytoplasm, thus limiting the usefulness of these viruses to detection of 
infected cells. By contrast, the reporters described in this dissertation are the first to 
express GFP or FFL from within the replicase gene. This design of recombinant reporter 
viruses resulted in expression of GFP as a fusion with nsps 2 or 3, and specific targeting 
of the GFP-nsps. This enabled the viruses to be used to study viral replication, replication 
complex formation, and ORF1a protein expression kinetics in live-infected cells. 
Although we had previously demonstrated that nsp2 could be deleted from the replicase 
polyprotein (Graham et al., 2005), viruses lacking nsp2 showed up to 90% decrease in 
peak replication. By contrast, recombinant viruses with reporters fused to nsp2 replicate 
with WT-like kinetics. The function of nsp2 is not known, and complementation by 
expression from other locations in the genome does not complement its deletion from its 
native encoded location (Gadlage et al., 2008). In addition, the reporter-nsp2 fusion 
viruses were unable to compete with WT virus. Thus, nsp2 appears to serve some role 
during infection that is not essential for replication but is important for overall virus 
fitness. The reporter-nsp2 viruses will allow direct testing of the expression, localization 
and functions of nsp2. As an example, the FFL-nsp2 virus allows direct measurement of 
translation of the replicase polyprotein 1a. I propose that multiple reporters might be 
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tolerated within one virus, as we have also successfully introduced GFP as a fusion with 
nsp14 in ORF1b (Eckerle, unpublished). Multiple reporters within one virus would be 
particularly useful to compare translation of ORF1a and ORF1b, to visualize protein 
interactions during replication complex formation, and to evaluate how viral proteins 
move from replication complexes to sites of assembly. 
 
Recently, I have tested a panel of MHV and SARS-CoV recombinant viruses expressing 
fluorescent and luminescent reporters (Table 2) including fluorophores such as EGFP and 
mRFP. We have also generated fusion protein viruses with fluorescent proteins for use in 
super-resolution fluorescence microscopy and correlative EM/fluorescence. Specifically, 
we have introduced photoactivatable proteins including mEOS and PA-GFP. We have 
demonstrated the ability to use either STORM (stochastic optical reconstruction 
microscopy) or PALM (photoactivatable light microscopy) to achieve up to 10-fold 
increase in resolution of complexes containing localized proteins (Figure 35). To date, 
little is known of the timing and mechanisms of membrane modification, replication 
complex formation, stasis or movement of nsps between replication complexes, or 
movement of newly synthesized viral RNA and nucleocapsids. Our ability to perform 
super-resolution microscopy of individual and multiple replicase proteins will allow us to 
answer these questions. Each of these viruses could be imaged during the course of 
infection and fluorescence could help us to map the paths of the proteins in a single cell 
during the entire course of infection without having to choose a specific time to fix cells.  
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Figure 35. STORM imaging of DBT cells infected with MHV-mEos-nsp2 
A) STORM image of a large area of an infected DBT cell. The fluorescence is directly 
from the mEos protein in the virus. Activated with low-level, continuous 405 nm laser, 
and collected images with the 546 nm laser. B) higher magnification of the same image. 
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While the reporter viruses generated in my study were stable for use up to five passages, 
with increased passage the reporter molecule was either inactivated or deleted.  
Specifically, with increased passage of MHV-Δ2-GFP3, the GFP sequence became 
unrecognizable and finally was completely excised by passage 20. Each incremental 
deletion of the reporter corresponded to a decreased eclipse phase in the replication 
curve, until upon complete removal of the GFP, the passage 20 version of MHV-Δ2-
GFP3 replicated with kinetics of the parent MHV-Δ2 virus. With increasing passage of 
MHV-Δ2-FFL3, a mutation inactivated FFL substrate binding, while leaving the rest of 
the sequence intact. Viruses with the reporter-nsp2 fusions have not been tested for 
reporter inactivation or deletion. This data raises the possibility of evaluating different 
locations within the genome for increased stability, or for using the selective loss of 
reporter function to investigate questions of viral fidelity, with and without a mutation in 
the proofreading exonuclease. Codon optimization could be employed to investigate if an 
optimal reporter molecule could be designed for a specific viral genome. A series of 
reporter viruses could be used to measure recombination during viral infection.  
 
Viruses containing reporters fused to nsp3 without a compensatory deletion of nsp2 have 
not been attempted, which would answer the question of if the replication defect was due 
to nsp2 loss alone or if it was more specifically related to the loss of a free nsp3 N 
terminus. The replication defect could be related to protease processing interference, 
difficulties in protein folding, or the interruption of localization signals. It could also be 
related to the size or shape of specific tags. This data raises the question of whether some 
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locations in the genome are better than others at creating either viable virus, or viable 
virus without replication defects.  
 
Entry-independent, constitutive macropinocytosis during CoV replication 
The capacity of CoVs to modify interior membranes during replication complex 
formation is well known.  In contrast, prior to my studies little was known of coronavirus 
interactions with or modifications to the plasma membrane, apart from functions in virus 
entry and egress.  This dissertation describes plasma membrane ruffling induced by both 
MHV and SARS-CoV infection that exhibit features of macropinocytosis. Prior to my 
work, macropinocytosis or a “macropinocytosis-like process” had been reported as an 
entry strategy utilized by 21 different viral pathogens since the first report in 2001 
(Marechal et al., 2001) (Table 3). Interestingly, viruses that use macropinocytosis have 
surprisingly little in common. Genomes represented include both positive and negative 
sense single stranded RNA, double stranded RNA, and segmented RNA and DNA. Viral 
particles range in size from 20 nm for porcine parvovirus to 500 µm for the filamentous 
form of influenza. While macropinocytosis has previously been described to be an 
important means of cellular entry for many viruses and bacteria, the present work 
describes the first known viral induction of macropinocytosis not associated with virus 
entry. Coronavirus induction of macropinocytosis is significant, since it represents a 
novel exploitation of macropinocytosis by a virus, likely for cell-cell movement. It also 
describes a previously unknown function for the spike protein and suggests that the spike 
protein interacts with or indirectly activates epidermal growth factor receptor, to initiate 
subsequent signaling events and actin modification resulting in macropinocytosis. 
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Overall, my work raises many additional questions and important future directions that 
can be explored: What is the role of macropinocytosis during CoV infection? Does 
fusogenic spike interact with EGFR to activate macropinocytosis? Does 
macropinocytosis enhance cell-to-cell spread during infection? 
	  
What is the role of macropinocytosis during CoV infection?  
Interestingly, MHV-A59 and MHV-2 spike proteins exhibit different capacities for 
macropinocytotic induction. These two viral strains differ in their entry mechanism, 
capacity for syncytia formation, and tropism, all of which are functions related to spike 
protein (Das Sarma et al., 2000; Navas et al., 2001). MHV-A59 is neurovirulent in mice, 
causing acute encephalitis and chronic demyelination, while MHV-2 has low 
neurovirulence, causing meningitis (Das Sarma et al., 2000). Spike is therefore an 
important mediator of tropism and pathogenesis, although it is not the sole regulatory 
factor of these parameters. Based on the results reported here, we conclude that MHV-2 
is unable to induce macropinocytosis, but this does not seem to have negative 
consequences on viral replication for this virus. In contrast, blocking macropinocytosis in 
MHV A59 infection does result in a drop in viral titer. Macropinocytosis and syncytia 
formation with MHV-2 can be restored with exogenous trypsin cleavage of spike protein 
on the cell surface. Macropinocytosis may have evolved during MHV infection as a 
tissue-specific advantage, or as a means to a competitive edge over non-macropinocytotic 
variants. It is important to understand whether or not the capacity to induce 
macropinocytosis confers increased fitness in vivo. Additionally, there are other strains of 
MHV that have more specific hepatic tropism, such as JHM, which could assist in 
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answering this question by utilizing the JHM spike protein in an isogenic MHV A59 
background. 
 
SARS-CoV spike has complicated and incompletely characterized mechanisms of entry 
and spike cleavage. While it has been suggested that SARS-CoV is endocytosed and 
spike is subject to cleavage by cathepsins in the endosome, like MHV-2, other proteases 
have been demonstrated to cleave SARS-CoV spike at the cell surface, including trypsin, 
TMPRSS, HAT, and others (Bosch et al., 2008; Du et al., 2007; Kam et al., 2009). This 
leads me to hypothesize that any spike protein that traffics to the surface of the cell can 
then be cleaved by these proteases in order to induce macropinocytosis. Additional 
studies are necessary to elucidate this mechanism.  
 
Does fusogenic spike interact with EGFR to activate macropinocytosis?  
Epidermal growth factor receptor (EGFR) is a member of the ErbB family of tyrosine 
kinases that includes HER2, HER3, and HER4 (Earp et al., 2003). Dysregulation of these 
family members can lead to cancer. The clinical importance of this cellular receptor has 
led to the development of several inhibitors, including gefitinib (Iressa), which was used 
during this dissertation project to inhibit EGFR and study the effect on macropinocytosis 
in CoV-infected cells. In addition to EGFR, the phosphatidyl serine receptor (PSR) and 
αv integrin are surface receptors that initiate macropinocytosis. Evaluating these 
additional pathways would determine if CoVs utilize multiple activating pathways for 
macropinocytosis. Additional data detailing when EGFR activation occurs during 
infection and the duration of activation would help to elucidate this novel viral-cell 
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interaction. Gefitinib has been shown to have some amount of cross reactivity, not with 
other family members, but with some other cellular targets, none of which are known 
activators of macropinocytosis (Brehmer et al., 2005). Use of some of the newer EGFR 
inhibitors may have less cross reactivity, and similar results with these alternative 
inhibitors would strengthen the conclusions already made.  
 
Elucidating the nature of the spike-EGFR interaction is also important. Do they directly 
interact or is there an intermediate step such as an adaptor protein or ligand that is 
necessary for activation? Another question to be addressed is whether spike and EGFR 
interact at the surface or in the interior of the cell. Because EGFR is recycled, it would be 
possible for EGFR and spike to be exocytosed in the same vesicle. Viruses, particularly 
papillomaviruses, have been shown to interact with receptor tyrosine kinases in a variety 
of ways, including through a transmembrane domain surface interaction, the production 
of a ligand that then exogenously activates the receptor, and other viruses through direct 
binding to the receptor (DiMaio and Petti, 2013). Which phosphorylation site leads to its 
activation? Is spike acting as a cross-linker to create a permanent EGFR dimer, or is it 
causing the phosphorylation of an EGFR monomer that leads to the activation of the 
macropinocytosis pathway?  
 
Does macropinocytosis enhance cell-to-cell spread during infection?  
While my work has identified that macropinocytosis is a putative mechanism for creating 
virological synapses necessary for cell to cell spread through the formation of large 
membrane ruffles and also filopodia, more experiments are necessary to discover if cell-
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cell spread is occurring in addition to syncytia formation. The length and frequency of 
filopodia should be measured during infection, as well as the change over time. 
Measurements of the interactions between filopodia and other cells should be noted, as 
well as the results of those interactions. More visual information about the relationship of 
budding virions or available surface spike protein and their relative position to filopodia 
forming would also be helpful in determining these relationships. An assay to measure 
cell-cell spread could also be a beneficial tool to evaluate changes in rate of formation or 
of plaque size. Polarized respiratory epithelial cells should be evaluated for their capacity 
for macropinocytosis after infection with coronaviruses. This system would help evaluate 
the hypothesis that CoVs are utilizing macropinocytosis to reach over tight junctions to 
infect neighboring cells. Other viruses have been shown to use cytoskeletal elements to 
form the virological synapse between cells; however, macropinocytosis has never been 
shown to be used for this purpose. In addition to the long extensions of actin, are the 
internalized vesicles also important for viral replication or are they simply a byproduct of 
the necessity for membranous extensions? What is in the vesicles, where do they deliver 
their cargo, and can they be halted independently of the membrane ruffles?   
 
Visualizing MERS-CoV replication using newly developed antibodies 
Chapter IV described the development of a panel of antibodies that recognized 
nonstructural proteins from the newly emergent pathogen, MERS-CoV. These antibodies 
were tested for specificity and used to investigate the spatial and temporal formation of 
replication complexes and their relationship to cellular markers. This work represents the 
first to visualize the formation of these complexes in this virus and also reports several 
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foundational, valuable, tested reagents that will be critical for future studies of these 
proteins for an important, newly emerged pathogen. 
 
Significance and applications of research 
CoVs will continue to pose a threat to human health, ranging from inconvenient common 
colds to life-threatening acute respiratory distress syndrome requiring significant medical 
intervention and supportive care. Even during the years spent working on this dissertation 
project, I have watched with fascination and awe the outbreak of a newly emergent 
coronavirus. It has provided an incredible exercise in epidemiology, frustration with the 
lack of information available, including the often inaccurate or inconsistent mortality and 
case counts, and curiosity about how the new virus works. It has been amazing to see 
how the scientific community reacted to a new virus. Papers emerged describing 
differences between this virus and SARS-CoV, serologic studies encompassing a wide 
variety of animals in the geographical area, the identification of the viral receptor, details 
about how best to screen and isolate new cases, and hypotheses about spread, emergence, 
and cross-species transmission. This outbreak has also presented learning opportunities 
about information sharing in the face of an emerging infection, regarding viral sequence 
information, samples, and reagents, what happens to the scientific enterprise if one group 
claims that an emerging virus is their intellectual property, and the importance of accurate 
case reporting from a region of the world with whom we do not always have cordial 
relations. 
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Historically, vaccination development has been a challenge for coronaviruses. 
Particularly, several vaccine strategies have been attempted for SARS-CoV including 
inactivating whole virus, spike (S) protein preparations, virus-like particles (VLPs), 
plasmid DNA and several vectors containing genes for SARS-CoV proteins (Tseng et al., 
2012). None of these vaccines are presently licensed for use, as most strategies had 
problems during animal testing, some causing strong immunogenic reactions upon post-
vaccination challenge with SARS-CoV. A strategy to attenuate viral fidelity showed 
promise during initial animal testing for safety and efficacy, and as proofreading activity 
is unique to coronaviruses, may represent a viable vaccination strategy for future 
emerging coronaviruses as well (Graham et al., 2012). Finding a strategy that could be 
applicable to future emerging coronaviruses is very appealing, as it would hasten our 
ability to control infections earlier in the initial period of emergence and uncertainty. 
Perhaps more important than the development of a vaccine, given these challenges, is the 
development of potent and effective anti-viral drugs that target coronaviruses. Through 
my work with macropinocytosis, in the understanding of a basic science mechanism, I 
utilized two inhibitors of this process that are used in clinical settings or are derivatives of 
approved drugs. Gefitinib, an EGFR inhibitor, is often used in cancer chemotherapy.  
Ethyl isopropyl amiloride is a derivative of amiloride, a blood pressure medication. 
Dosage information for halting macropinocytosis in humans is currently unknown, and 
the safety of blocking macropinocytosis in humans is also yet to be determined, as it is a 
process used by healthy cells, but because so many viruses without other shared 
characteristics utilize macropinocytosis, blocking it seems an interesting an 
uninvestigated strategy for a pan-viral inhibitor. 
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From a more basic-science perspective, my work also identified a new function for 
macropinocytosis in the life cycle of a virus, one unrelated to entry. It would be 
interesting to investigate other viruses that use macropinocytosis for entry for their 
capacity to use macropinocytosis at other points during the life cycle. 
 
In conclusion, all scientific research serves to understand one tiny piece of the world in 
order to see how the pieces fit together to benefit society. The work described in this 
thesis represents years of my learning and development as a scientist and also my current 
contribution to furthering human understanding of host-pathogen interactions. It is my 
hope that the results of these studies will act as building blocks for many studies to follow 
exploring how viruses are able to exploit cellular processes for their own purposes. And 
in this way, one block at a time, we will be able to predict viral emergence, understand 
the intricacies of viral replication, and generate cures to alleviate human suffering.  
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Table 2. Generated reporter viruses 
 
 
nsp1-repoter-nsp2 Virus P1 Titer 
mCherry 1.3x10^8 
mEos2 3.3x10^8 
EGFP 1.0x10^8 
mRFP 7.0x10^7 
FFL 6.8x10^7 
nsp1-reporter-nsp3 Virus  
mCherry 1.0x10^7 
mEos2 3.7x10^7 
EGFP 7.0x10^7 
mRFP 1.5x10^6 
FFL 4.2x10^7 
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Table 3. Viruses that utilize macropinocytosis (MPC) for entry  
 
Virus Genome Size When 
Main or 
Alternative
? MPC 
MPC-
like Reference 
adenovirus 2 dsDNA 
90-100 
nm 
egress from 
endosome 
clathrin for 
entry x   (Meier et al., 2002) 
adenovirus 3 dsDNA 
90-100 
nm entry main x   (Amstutz et al., 2008) 
adenovirus 
35 dsDNA 
90-100 
nm entry main x   (Kalin et al., 2010) 
African 
Swine Fever dsDNA 200 nm entry main x   (Sanchez et al., 2012)  
bluetounge 
virus 1 dsRNA 86 nm entry main   x (Gold et al., 2010) 
Dengue 
virus ssRNA + 50 nm entry 
clathrin 
main, MPC 
alternative x   
(Suksanpaisan et al., 
2009) 
ebola ssRNA - 
920 nm  
long, 80 
nm 
diameter entry main x   
(Saeed et al., 2010) 
        main x   (Nanbo et al., 2010) 
      
  
main, 
clathrin as 
minor x   
(Aleksandrowicz et 
al., 2011) 
      
  
main, 
though 
atypical x   
(Mulherkar et al., 
2011) 
        main x    (Wen et al., 2013) 
Epstein Barr 
Virus DNA 
120-180 
nm 
apical to 
basolateral 
transcytosis main x   
(Tugizov et al., 2013) 
echovirus 1 ssRNA + 
24-30 
nm entry main x   (Krieger et al., 2013) 
HCMV DNA 
100-150 
nm entry 
dendritic 
cells   x (Haspot et al., 2012) 
HIV-1 retrovirus 120 nm 
entry 
alternative/c
ell type 
dependent x   
(Marechal et al., 
2001) 
      entry main x   (Liu et al., 2002) 
      entry 
dendritic 
cells  x   (Wang et al., 2008) 
      entry main   x (Carter et al., 2011) 
      entry alternative   x (Gobeil et al., 2013) 
HPV-16 DNA 600 nm entry 
main, 
pseudovirus    x 
(Schelhaas et al., 
2012) 
human 
rhinovirus 
14 ssRNA + 30 nm 
entry 
main   x 
(Khan et al., 2010)  
Influenza 
segmented 
RNA - 
80-120 
nm, 
filament
ous ≤500 
um  entry 
alternative 
for 
influenza, 
main for 
filamentous 
influenza x   
(Rossman et al., 2012) 
KSHV DNA 100-150 entry epithelial   x (Raghu et al., 2009) 
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nm cells not 
fibroblasts 
LASV and 
Junin virus, 
LCMV 
ssRNA, 
ambisense
, ssRNA - 
lassa: 
120 nm 
junin: 
50-300 
nm entry main x    
(Iwasaki et al., 2014) 
Nipah Virus ssRNA - 
40-600 
nm entry 
direct 
fusion or 
MPC x   
(Pernet et al., 2009) 
Porcine 
Parvovirus ssDNA 20 nm entry 
clathrin and 
MPC 
(aggregate 
particles) x   
(Boisvert et al., 2010) 
Vaccinia 
Virus 
linear ds 
DNA 
360 × 
270 × 
250 nm 
 entry 
main x   
(Mercer and Helenius, 
2008) 
      
  
filopodia 
(Cdc42) vs. 
blebbing 
(Rac1) x   
(Mercer et al., 2010) 
      
  
intracellular 
mature 
virus (MV) 
(alternative) 
and 
extracellula
r enveloped 
virus (EV) 
main x   
(Sandgren et al., 
2010) 
        
EVs using 
MPC x   (Schmidt et al., 2011) 
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Appendix A: CORONAVIRUS REPLICASE-REPORTER FUSIONS PROVIDE 
QUANTITATIVE ANALYSIS OF REPLICATION AND REPLICATION 
COMPLEX FORMATION 
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Appendix B: PEDIATRICS CORONAVIRUS CHAPTER 
I wrote the following text as a chapter for the 19th edition of the book Pediatrics. 
 
 
Introduction 
Coronaviruses are increasingly recognized as important human pathogens. They cause up 
to 15% of common colds and have been implicated in more serious diseases including 
croup, asthma exacerbations, bronchiolitis, and pneumonia. Evidence also suggests that 
coronaviruses may cause enteritis or colitis in neonates and infants and may be 
underappreciated as agents of meningitis or encephalitis. Four coronaviruses are endemic 
in humans: human coronaviruses (HCoV) 229E, OC43, NL63, and HKU1. In addition, 
two epidemics of previously unknown coronaviruses caused significant respiratory 
distress and high mortality rates among infected individuals. The discoveries of SARS-
associated coronavirus (SARS-CoV), the cause of severe acute respiratory syndrome 
(SARS) in 2003, and of Middle East Respiratory Syndrome-CoV (MERS-COV) in 2012 
support the potential for coronaviruses to emerge from animal hosts such as bats and 
become important human pathogens.  
 
Etiology 
Coronaviruses are enveloped viruses of medium to large size (80-220 nm) that possess 
the largest known single-stranded positive-sense RNA genomes. Recently, these viruses 
were shown to encode the protein nsp14-ExoN, which is the first known RNA 
proofreading enzyme and is likely responsible for the evolution of the large and complex 
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coronavirus genome (Denison et al., 2011). Coronaviruses derive their name from the 
characteristic surface projections of spike protein, which give a corona or crown-like 
appearance on negative-stain electron microscopy. Coronaviruses are organized 
taxonomically by a lettering system based on genomic phylogenetic relationships (van 
Boheemen et al., 2012). Alphacoronaviruses include human coronavirus 229E (HCoV-
229E) and HCoV-NL63. Betacoronaviruses include four human pathogens and are 
commonly divided into four lineages, without formal taxonomic recognition. HCoV-
OC43 and the HCoV-HKU1 are in lineage A, while SARS-CoV falls in lineage B. 
Lineages C and D were exclusively comprised of bat coronaviruses until the discovery of 
MERS-CoV, which aligns with lineage C. Gammacoronaviruses and deltacoronaviruses 
presently include exclusively non-human pathogens. 
 
In 2002-2003, coronaviruses received international attention during the SARS outbreak, 
which was responsible for over 800 deaths in 30 countries. SARS-CoV, a novel 
coronavirus at the time of the epidemic, was found to be the causative agent of SARS. 
The detection of SARS-like coronaviruses in a live animal market in the Guangdong 
province in southern China, along with serologic evidence of exposure in food handlers 
in the same market, suggest that these markets may have facilitated the spread of SARS-
CoV to humans from an animal reservoir. Subsequent studies identified SARS-like 
coronaviruses that are very closely related, but not direct precursors to, SARS-CoV in 
fecal specimens from asymptomatic Chinese horseshoe bats. Thus, although bats are 
thought to be a reservoir for SARS-like precursors, the precise antecedent to SARS-CoV 
remains to be identified. 
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In June 2012, another novel coronavirus, MERS-CoV was isolated from a man with acute 
pneumonia and renal failure in Saudi Arabia (Zaki et al., 2012). To date, an additional 
827 cases have been confirmed in Saudi Arabia, UAE, Qatar, Jordan, Tunisia, France, 
Italy, and the United Kingdom. Two hundred and eighty seven of these patients died due 
to their infection. MERS-CoV differs from SARS in that seems to be less communicable, 
although human-to-human transmission has been confirmed (Perlman and Zhao, 2013). 
MERS-CoV has been shown to use dipeptidyl peptidase 4 (DPP4) as its cellular receptor, 
a difference between MERS-CoV and SARS-CoV which utilizes ACE-2, and is able to 
infect cells from several animal lineages, including human, pig, and bat, suggesting the 
possibility of movement between multiple species (Raj et al., 2013). Serologic studies in 
several domestic species in Saudi Arabia have demonstrated that nearly 100% of 
dromedary camels tested for antibodies to MERS-CoV were positive, and evidence of 
MERS-CoV antibodies were identified in samples from as long ago as 1992, while other 
herd animals tested in the region were negative for these antibodies as were dromedary 
camels tested in other regions of the world. A short MERS-CoV sequence was also 
discovered in a bat from the region. The way MERS-CoV is transmitted to humans, 
however, is still to be determined.  
 
Epidemiology 
Seroprevalence studies have demonstrated that antibodies against 229E and OC43 
increase rapidly during early childhood, so that by adulthood 90-100% of persons are 
seropositive. Although less information is available for HKU1 and NL63, studies 
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demonstrate similar patterns of seroconversion to these viruses during early childhood. 
Although some degree of strain-specific protection may be afforded by recent infection, 
re-infections are common and occur despite the presence of strain-specific antibodies. 
Attack rates are similar in different age groups. Although infections occur throughout the 
year, there is a peak during the winter and early spring for each of these HCoVs 
(Dominguez et al., 2009). In the US, outbreaks of OC43 and 229E have occurred in 2- to 
3-year alternating cycles. Independent studies of viral etiologies of upper and lower 
respiratory infections during the same period, but from different countries, have 
confirmed that all known human coronaviruses have a worldwide distribution. Studies 
using both viral culture and PCR multiplex assays have demonstrated that coronaviruses 
often occur as co-infections with other respiratory viruses, including respiratory syncytial 
virus (RSV), adenovirus, rhinovirus (RV), or human metapneumovirus (HMPV) 
(Stempel et al., 2009). Volunteer studies demonstrated that OC43 and 229E are 
transmitted predominantly through the respiratory route. Droplet spread appears to be 
most important, although aerosol transmission may also occur.  
 
There have been no identified natural or laboratory-acquired cases of SARS-CoV since 
2004, but the mechanisms of introduction, spread, and disease remain important for 
potential animal-to-human transmission and disease. The primary mode of SARS-CoV 
transmission occurred through direct or indirect contact of mucous membranes with 
infectious droplets or fomites. Aerosol transmission was less common, occurring 
primarily in the setting of endotracheal intubation, bronchoscopy, or treatment with 
aerosolized medications. Fecal-oral transmission did not appear to be an efficient mode 
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of transmission but may have occurred because of the profuse diarrhea observed in some 
patients. The seasonality of SARS-CoV remains unknown. SARS-CoV is not highly 
infectious, with generally only 2-4 secondary cases resulting from a single infected adult. 
During the SARS epidemic, a small number of infected individuals, “super-spreaders”, 
transmitted infection to a much larger number of persons, but the mechanism for this high 
degree of spread remains unknown. In contrast, persons with mild disease, such as 
children under twelve years of age, rarely transmitted the infection to others (Bitnun et 
al., 2009). Infectivity correlated with disease stage; transmission occurred almost 
exclusively during symptomatic disease. During the 2003 outbreak, most individuals with 
SARS-CoV infection were hospitalized within 3-4 days of symptom onset. Consequently, 
most subsequent infections occurred within hospitals and involved either health care 
workers or other hospitalized patients.  
 
Pathogenesis 
Coronaviruses have been reported to cause minimal cytopathology. Studies with SARS-
CoV in human airway epithelial cell cultures indicate that ciliated cells are principal 
targets for infection and that infected ciliated cells may be directly extruded or lost from 
the infected monolayer. Thus, the cytopathology from other HCoVs may be due to direct 
cell infection and loss, though symptoms may also be due to the host immune response.  
Infection with OC43 and 229E is associated with the elaboration of cytokines, including 
interleukin-8 (IL-8) and interferon-γ (IFN-γ). In experimentally infected volunteers, 
serum-specific immunoglobulin (Ig) A and IgG antibody levels peak 12-14 days after 
infection but decline rapidly thereafter. At one year following experimental infection, 
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there is only partial protection against re-infection with the homologous strain, suggesting 
a challenge for the development of successful vaccines against HCoVs.   
 
Clinical Manifestations 
While all known human coronaviruses cause respiratory disease, the role of human 
coronaviruses in gastrointestinal and neurologic disease is less clear and remains to be 
proven. In addition to severe respiratory pathology, both SARS-CoV and MERS-CoV 
can cause renal failure, although this symptom is observed less frequently during SARS-
CoV infections. 
 
Respiratory Infections 
Even though up to 50% of respiratory tract infections with OC43 and 229E are 
asymptomatic, coronaviruses are still responsible for up to 15% of common colds. Cold 
symptoms caused by human coronaviruses are indistinguishable from those caused by 
rhinoviruses and other respiratory viruses. The average incubation period is 2-4 days, 
with symptoms typically lasting 4-7 days (Lessler et al., 2009). Rhinorrhea, cough, sore 
throat, malaise, and headache are the most common symptoms. Fever occurs in up to 
60% of cases. Coronavirus NL63 is a cause of croup in children under three years of age. 
Coronavirus infections have been linked to episodes of wheezing in asthmatic children, 
albeit at a lower frequency and severity than observed with rhinovirus and respiratory 
syncytial virus infections. Lower respiratory tract infections, including bronchiolitis and 
pneumonia, have also been reported in immunocompetent and immunocompromised, 
children and adults. As with RSV or RV, coronavirus detection in upper respiratory 
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infections is frequently associated with acute otitis media and can be isolated from 
middle ear fluid (Alper et al., 2009). 
 
Non-Respiratory Sequelae 
There is some evidence to support a role for coronaviruses in human gastrointestinal (GI) 
disease, particularly in young children. Coronavirus-like particles have been detected by 
electron microscopy in the stools of infants with nonbacterial gastroenteritis. In addition, 
several outbreaks in neonatal intensive care units of gastrointestinal disease characterized 
by diarrhea, bloody stools, abdominal distention, bilious gastric aspirates, and classic 
necrotizing enterocolitis have also been associated with the presence of coronavirus-like 
particles in stools. In older children and adults, coronavirus-like viruses have been 
observed with similar frequency in symptomatic and asymptomatic individuals, making it 
difficult to discern if they are pathogenic in the GI tract. Coronaviruses are well-known 
causes of neurologic disease in animals, including demyelinating encephalitis, but their 
role in causing human neurologic disease remains unclear. Coronaviruses have been 
detected by culture, in situ hybridization, and reverse transcriptase polymerase chain 
reaction (RT-PCR) in brain tissue from a few patients with multiple sclerosis. However, 
coronavirus RNA has also been recovered from the spinal fluid and brain tissue of adults 
without neurologic disease. HCoV-OC43 has been detected by RT-PCR in the spinal 
fluid and nasopharynx of one child with acute disseminated encephalomyelitis. 
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SARS-CoV 
SARS-CoV infections in teenagers and adults included a viral replication phase and an 
immunologic phase. During the viral replication phase there was a progressive increase in 
viral load that reached its peak during the second week of illness. The appearance of 
specific antibodies coincided with peak viral replication. The clinical deterioration that 
typified the second and third week of illness was characterized by a decline in the viral 
load and evidence of tissue injury likely from cytokine-mediated immunity. The 
explanation for milder clinical disease in children less than 12 years of age has not been 
determined. Seroepidemiologic studies suggest that asymptomatic SARS-CoV infections 
were uncommon. The incubation period ranged from 1 to 14 days, with a median of 4-6 
days. The clinical manifestations were nonspecific, most commonly consisting of fever, 
cough, malaise, coryza, chills or rigors, headache, and myalgia. Coryza was more 
common in children less than 12 years of age, whereas systemic symptoms were seen 
more often in teenagers. Some young children had no respiratory symptoms. 
Gastrointestinal symptoms, including diarrhea and nausea or vomiting, occurred in up to 
a third of cases. The clinical course of SARS-CoV infection varied with age. Adults were 
most severely affected, with initial onset of fever, cough, chills, myalgia, malaise, and 
headache. Following an initial improvement at the end of the first week, fever recurred 
and respiratory distress developed, with dyspnea, hypoxemia, and diarrhea. These 
symptoms progressed in 20% of patients to acute respiratory distress syndrome (ARDS) 
and respiratory failure. Acute renal failure with histological acute tubular necrosis was 
present in 6.9% of patients, likely due to hypoxic kidney damage. 28.8% of SARS 
patients had abnormal urinalysis, with viral genome detectable by qRT-PCR. In contrast, 
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children under 12 years of age had a relatively mild nonspecific illness, with only a 
minority experiencing significant lower respiratory tract disease and illness typically 
lasting less than five days. There were no deaths or ARDS in children under 12 years of 
age from SARS-CoV infection. Adolescents manifested increasing severity in direct 
correlation to increasing age; respiratory distress and hypoxemia were observed in 10-
20% of patients, one third of which required ventilator support. The case fatality rate 
from SARS-CoV infection during the 2003 outbreak was 10-17%. No pediatric deaths 
were reported. The estimated case fatality rate according to age varied from <1% for 
those under 20 years of age to >50% for those over 65 years of age. 
 
MERS-CoV 
The incubation period of MERS-CoV is thought to be approximately ten days. Because 
of the relatively low rate of spread, it is considered to be less transmissible from person to 
person than SARS-CoV. Several clusters of patients have been diagnosed with confirmed 
cases, though it is difficult to determine if their infections were spread from person to 
person or if they shared a common environmental exposure. A cluster in the UK 
confirmed person-person transmission, as only one of the individuals had traveled to the 
Arabian Peninsula. Because the method of transmission is presently unknown, 
appropriate airborne and contact precautions are required when treating infected patients. 
Patients have presented with acute respiratory infection, a fever higher than 100.4 degrees 
F, cough, and pulmonary parenchymal disease such as pneumonia or ARDS. 
Lymphopenia, neutrophilia, and late thrombocytopenia occurred in the index-case 
patient. This patient also had progressive renal impairment, beginning on the ninth day of 
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symptoms which continued to progress until the patient’s death at day 11. The case 
fatality rate is presently >35% for confirmed cases. A low percentage of pediatric cases 
have been discovered upon screening contacts of infected adults, though most have been 
asymptomatic (Memish et al., 2014).  
 
Diagnosis 
In the past, specific diagnostic tests for coronavirus infections were not available in most 
clinical settings. The use of conserved PCR primers for coronaviruses in multiplex RT-
PCR viral diagnostic panels now allows widely available and sensitive detection of the 
viruses. Virus culture of primary clinical specimens remains a challenge for HCoVs 
HKU1, OC43, 229E and NL63, while both SARS-CoV and MERS-CoV can both 
successfully be grown in culture from respiratory samples. Serodiagnosis with 
complement fixation, neutralization, hemagglutination inhibition, enzyme immunoassay, 
or Western blots has been used in the research setting. The diagnosis of SARS-CoV 
infection can be confirmed by serologic testing, detection of viral RNA using RT-PCR, 
or isolation of the virus in cell culture. While serology for SARS-CoV has sensitivity and 
specificity approaching 100%, antibodies are not detectable until 10 days after the onset 
of symptoms, and IgG seroconversion may be delayed for up to 4 weeks. In addition, the 
SARS epidemic resulted in the inclusion of CoV conserved primers in many diagnostic 
PCR multiplex assays such that CoVs may be more readily detected. For emerging CoVs, 
such as MERS-CoV, highly conserved primers were used for initial detection, with 
confirmatory assays using specific primers. Thus, the mainstay of early diagnosis is RT-
PCR. For all known endemic and emerging HCoVs, respiratory specimens 
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(nasopharyngeal swabs or aspirates) are most likely to be positive, but in a setting of a 
possible novel CoV, serum or stool may be positive. Two highly sensitive real-time RT-
PCR assays are currently available for testing for MERS-CoV RNA in addition to 
utilizing immunofluorescence microscopy for the detection of antibody response.   
 
Treatment and Prevention 
Coronavirus infections of humans are acute and self-limited, although persistent infection 
and shedding may occur in multiple animal models in the setting of minimal or no 
symptomology. There are no available antiviral agents for clinical use against 
coronaviruses, although strategies targeting conserved coronavirus proteases have been 
shown to block replication of the virus in vitro. Challenges for development of effective 
vaccines targeted against OC43, 229E, HKU1, and NL63 include the fact that infections 
are rarely life threatening and re-infection is the rule, even in the presence of natural 
immunity from previous infections.  Treatment of SARS-CoV and MERS-CoV infections 
is primarily supportive. The role of antiviral and immune-modulating agents remains 
inconclusive, largely because none of these therapies have been evaluated in properly 
conducted randomized controlled trials. Ribavirin was extensively used during the 2003 
SARS-CoV outbreak, but is of questionable benefit given its poor in vitro activity against 
SARS-CoV at clinically relevant concentrations. The identification of the proofreading 
nsp14-exonuclease suggests that this activity may be important in resistance to antiviral 
nucleosides and RNA mutagens such as ribavirin. Systemic corticosteroid therapy was 
temporally associated with clinical improvement in some patients. In another small, 
open-label, nonrandomized pilot study, interferon-α was associated with more rapid 
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resolution of oxygen requirements and radiographic abnormalities. Human monoclonal 
antibodies derived from SARS patients demonstrate broad neutralization against early 
and late epidemic strains of SARS-CoV and could potentially be therapeutic. 
Effective vaccines for SARS-CoV and MERS-CoV are highly desirable, but not yet 
available. A potential vaccine strategy would be to use the viral spike protein, which 
could be delivered as a recombinant protein or via viral or DNA vectors. This approach 
appears to be effective against closely related strains of SARS-CoV, but not necessarily 
early animal or human variants. A SARS-CoV vaccine approach that recently has shown 
success in animal models utilized a live-engineered SARS-CoV mutant with inactivated 
nsp14 exonuclease, demonstrating attenuation and protection in a variety of aged, 
immunocompromised mice (Graham et al., 2012). Approaches for rapid development of 
stably attenuated live viruses or broadly immunogenic and cross-protective protein 
immunogens continues to be a key area for future research. Although SARS-CoV 
demonstrated characteristics of symptomatic transmission that made it controllable by 
public health measures like quarantine, these characteristics cannot be assumed for future 
novel human coronaviruses. The recent outbreak of MERS-CoV serves as a reminder that 
coronavirus emergence is both likely and unpredictable, making it very important to 
continue studies of their replication, emergence, and transmission. Additionally, 
strategies for rapid recovery, testing, and development of vaccines and neutralizing 
human monoclonal antibodies may be essential to prevent the high morbidity and 
mortality associated with previous epidemics.  
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